{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T12:32:14Z","timestamp":1794918734263,"version":"4.9.1"},"reference-count":418,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG085545"],"award-info":[{"award-number":["R01 AG085545"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01 AG061872"],"award-info":[{"award-number":["R01 AG061872"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1 AG061729"],"award-info":[{"award-number":["RF1 AG061729"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T32 AG021890"],"award-info":[{"award-number":["T32 AG021890"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG066546"],"award-info":[{"award-number":["P30 AG066546"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG013319"],"award-info":[{"award-number":["P30 AG013319"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG044271"],"award-info":[{"award-number":["P30 AG044271"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008635","name":"University of Texas Health Science Center at San Antonio","doi-asserted-by":"publisher","award":["University of Texas Health Science Center at San Antonio"],"award-info":[{"award-number":["University of Texas Health Science Center at San Antonio"]}],"id":[{"id":"10.13039\/100008635","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020114","name":"Methodist Hospital Foundation","doi-asserted-by":"publisher","award":["Methodist Hospital Foundation"],"award-info":[{"award-number":["Methodist Hospital Foundation"]}],"id":[{"id":"10.13039\/100020114","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007625","name":"Cure Alzheimer's Fund","doi-asserted-by":"publisher","award":["Cure Alzheimer's Fund"],"award-info":[{"award-number":["Cure Alzheimer's Fund"]}],"id":[{"id":"10.13039\/100007625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013030","name":"William and Ella Owens Medical Research Foundation","doi-asserted-by":"publisher","award":["William and Ella Owens Medical Research Foundation"],"award-info":[{"award-number":["William and Ella Owens Medical Research Foundation"]}],"id":[{"id":"10.13039\/100013030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurodegeneration"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Alzheimer\u2019s disease (AD) is among the most devastating neurodegenerative disorders with limited treatment options. Emerging evidence points to the involvement of lipid dysregulation in the development of AD. Nevertheless, the precise lipidomic landscape and the mechanistic roles of lipids in disease pathology remain poorly understood. This review aims to highlight the significance of lipidomics and lipid-targeting approaches in the diagnosis and treatment of AD. We summarized the connection between lipid dysregulation in the human brain and AD at both genetic and lipid species levels. We briefly introduced lipidomics technologies and discussed potential challenges and areas of future advancements in the lipidomics field for AD research. To elucidate the central role of lipids in converging multiple pathological aspects of AD, we reviewed the current knowledge on the interplay between lipids and major AD features, including amyloid beta, tau, and neuroinflammation. Finally, we assessed the progresses and obstacles in lipid-based therapeutics and proposed potential strategies for leveraging lipidomics in the treatment of AD.<\/jats:p>","DOI":"10.1186\/s13024-025-00803-6","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T12:19:49Z","timestamp":1737980389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":74,"title":["Lipidome disruption in Alzheimer\u2019s disease brain: detection, pathological mechanisms, and therapeutic implications"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3786-8770","authenticated-orcid":false,"given":"Sijia","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3725-7726","authenticated-orcid":false,"given":"Ziying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8615-2413","authenticated-orcid":false,"given":"Xianlin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"803_CR1","doi-asserted-by":"publisher","first-page":"3740461","DOI":"10.1155\/2018\/3740461","volume":"2018","author":"KB Magalingam","year":"2018","unstructured":"Magalingam KB, Radhakrishnan A, Ping NS, Haleagrahara N. Current concepts of neurodegenerative mechanisms in Alzheimer\u2019s Disease. Biomed Res Int. 2018;2018:3740461.","journal-title":"Biomed Res Int"},{"issue":"2","key":"803_CR2","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/ana.21706","volume":"66","author":"JA Schneider","year":"2009","unstructured":"Schneider JA, Arvanitakis Z, Leurgans SE, Bennett DA. The neuropathology of probable Alzheimer disease and mild cognitive impairment. Ann Neurol. 2009;66(2):200\u20138.","journal-title":"Ann Neurol"},{"key":"803_CR3","unstructured":"Centers for Disease Control and Prevention, National Center for Health Statistics. National Vital Statistics, System. Mortality 2018\u20132021 on CDC WONDER online database, released in 2021. National Center for Health Statistics; 2021. Accessed in December, 2023. http:\/\/wonder.cdc.gov\/ucd-icd10-expanded.html."},{"key":"803_CR4","doi-asserted-by":"crossref","unstructured":"2024 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024;20(5):3708\u2013\u2009821.","DOI":"10.1002\/alz.13809"},{"issue":"4","key":"803_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1177\/0891988710383571","volume":"23","author":"LM Bekris","year":"2010","unstructured":"Bekris LM, Yu CE, Bird TD, Tsuang DW. Genetics of Alzheimer disease. J Geriatr Psychiatry Neurol. 2010;23(4):213\u201327.","journal-title":"J Geriatr Psychiatry Neurol"},{"issue":"4","key":"803_CR6","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","volume":"71","author":"GS Bloom","year":"2014","unstructured":"Bloom GS. Amyloid-beta and tau: the trigger and bullet in Alzheimer disease pathogenesis. JAMA Neurol. 2014;71(4):505\u20138.","journal-title":"JAMA Neurol"},{"issue":"1","key":"803_CR7","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H. Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther. 2023;8(1):267.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"803_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41536-020-00107-x","volume":"5","author":"P Norat","year":"2020","unstructured":"Norat P, Soldozy S, Sokolowski JD, Gorick CM, Kumar JS, Chae Y, et al. Mitochondrial dysfunction in neurological disorders: exploring mitochondrial transplantation. NPJ Regen Med. 2020;5(1):22.","journal-title":"NPJ Regen Med"},{"issue":"4","key":"803_CR9","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2174\/157015911798376190","volume":"9","author":"SJ Allen","year":"2011","unstructured":"Allen SJ, Watson JJ, Dawbarn D. The neurotrophins and their role in Alzheimer\u2019s disease. Curr Neuropharmacol. 2011;9(4):559\u201373.","journal-title":"Curr Neuropharmacol"},{"issue":"12","key":"803_CR10","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1016\/j.devcel.2024.03.030","volume":"59","author":"M Bretou","year":"2024","unstructured":"Bretou M, Sannerud R, Escamilla-Ayala A, Leroy T, Vrancx C, Van Acker ZP, et al. Accumulation of APP C-terminal fragments causes endolysosomal dysfunction through the dysregulation of late endosome to lysosome-ER contact sites. Dev Cell. 2024;59(12):1571\u201392. e9.","journal-title":"Dev Cell"},{"issue":"1","key":"803_CR11","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0002-9440(10)64538-5","volume":"157","author":"AM Cataldo","year":"2000","unstructured":"Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon RA. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer\u2019s disease and Down syndrome: differential effects of APOE genotype and presenilin mutations. Am J Pathol. 2000;157(1):277\u201386.","journal-title":"Am J Pathol"},{"key":"803_CR12","doi-asserted-by":"publisher","first-page":"04","DOI":"10.3389\/fnagi.2018.00004","volume":"10","author":"MS Uddin","year":"2018","unstructured":"Uddin MS, Stachowiak A, Mamun AA, Tzvetkov NT, Takeda S, Atanasov AG, et al. Autophagy and Alzheimer\u2019s Disease: from Molecular mechanisms to therapeutic implications. Front Aging Neurosci. 2018;10:04.","journal-title":"Front Aging Neurosci"},{"key":"803_CR13","doi-asserted-by":"publisher","first-page":"1281338","DOI":"10.3389\/fnagi.2023.1281338","volume":"15","author":"H Barmaki","year":"2023","unstructured":"Barmaki H, Nourazarian A, Khaki-Khatibi F. Proteostasis and neurodegeneration: a closer look at autophagy in Alzheimer\u2019s disease. Front Aging Neurosci. 2023;15:1281338.","journal-title":"Front Aging Neurosci"},{"issue":"7618","key":"803_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature19323","volume":"537","author":"J Sevigny","year":"2016","unstructured":"Sevigny J, Chiao P, Bussiere T, Weinreb PH, Williams L, Maier M, et al. The antibody aducanumab reduces Abeta plaques in Alzheimer\u2019s disease. Nature. 2016;537(7618):50\u20136.","journal-title":"Nature"},{"issue":"1","key":"803_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in Early Alzheimer\u2019s Disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"6","key":"803_CR16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jama.2023.13239","volume":"330","author":"JR Sims","year":"2023","unstructured":"Sims JR, Zimmer JA, Evans CD, Lu M, Ardayfio P, Sparks J, et al. Donanemab in early symptomatic Alzheimer Disease: the TRAILBLAZER-ALZ 2 Randomized Clinical Trial. JAMA. 2023;330(6):512\u201327.","journal-title":"JAMA"},{"issue":"2","key":"803_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrm2330","volume":"9","author":"G Van Meer","year":"2008","unstructured":"Van Meer G, Voelker DR, Feigenson GW. Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008;9(2):112\u201324.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"803_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ymgme.2008.06.012","volume":"95","author":"S Wang","year":"2008","unstructured":"Wang S, Soni KG, Semache M, Casavant S, Fortier M, Pan L, et al. Lipolysis and the integrated physiology of lipid energy metabolism. Mol Genet Metab. 2008;95(3):117\u201326.","journal-title":"Mol Genet Metab"},{"issue":"10","key":"803_CR19","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1016\/j.devcel.2021.03.034","volume":"56","author":"AS Mutlu","year":"2021","unstructured":"Mutlu AS, Duffy J, Wang MC. Lipid metabolism and lipid signals in aging and longevity. Dev Cell. 2021;56(10):1394\u2013407.","journal-title":"Dev Cell"},{"issue":"8","key":"803_CR20","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/nrm2934","volume":"11","author":"A Shevchenko","year":"2010","unstructured":"Shevchenko A, Simons K. Lipidomics: coming to grips with lipid diversity. Nat Rev Mol Cell Biol. 2010;11(8):593\u20138.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"803_CR21","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1194\/jlr.E400004-JLR200","volume":"46","author":"E Fahy","year":"2005","unstructured":"Fahy E, Subramaniam S, Brown HA, Glass CK, Merrill AH Jr., Murphy RC, et al. A comprehensive classification system for lipids. J Lipid Res. 2005;46(5):839\u201361.","journal-title":"J Lipid Res"},{"issue":"SupplSuppl","key":"803_CR22","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1194\/jlr.R800095-JLR200","volume":"50","author":"E Fahy","year":"2009","unstructured":"Fahy E, Subramaniam S, Murphy RC, Nishijima M, Raetz CR, Shimizu T, et al. Update of the LIPID MAPS comprehensive classification system for lipids. J Lipid Res. 2009;50(SupplSuppl):S9\u201314.","journal-title":"J Lipid Res"},{"issue":"2","key":"803_CR23","doi-asserted-by":"publisher","first-page":"100164","DOI":"10.1016\/j.jlr.2021.100164","volume":"63","author":"X Han","year":"2022","unstructured":"Han X, Gross RW. The foundations and development of lipidomics. J Lipid Res. 2022;63(2):100164.","journal-title":"J Lipid Res"},{"issue":"1","key":"803_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s12031-007-0060-1","volume":"33","author":"JA Hamilton","year":"2007","unstructured":"Hamilton JA, Hillard CJ, Spector AA, Watkins PA. Brain uptake and utilization of fatty acids, lipids and lipoproteins: application to neurological disorders. J Mol Neurosci. 2007;33(1):2\u201311.","journal-title":"J Mol Neurosci"},{"issue":"2","key":"803_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/0163-7827(85)90011-6","volume":"24","author":"PS Sastry","year":"1985","unstructured":"Sastry PS. Lipids of nervous tissue: composition and metabolism. Prog Lipid Res. 1985;24(2):69\u2013176.","journal-title":"Prog Lipid Res"},{"issue":"5961","key":"803_CR26","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1126\/science.1174621","volume":"327","author":"D Lingwood","year":"2010","unstructured":"Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science. 2010;327(5961):46\u201350.","journal-title":"Science"},{"issue":"1","key":"803_CR27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/1073858410373835","volume":"17","author":"G Saher","year":"2011","unstructured":"Saher G, Quintes S, Nave KA. Cholesterol: a novel regulatory role in myelin formation. Neuroscientist. 2011;17(1):79\u201393.","journal-title":"Neuroscientist"},{"key":"803_CR28","doi-asserted-by":"crossref","unstructured":"Jove M, Mota-Martorell N, Obis E, Sol J, Martin-Gari M, Ferrer I et al. Lipid adaptations against oxidative challenge in the healthy adult human brain. Antioxid (Basel) 2023;12(1).","DOI":"10.3390\/antiox12010177"},{"key":"803_CR29","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fnagi.2015.00052","volume":"7","author":"SC Dyall","year":"2015","unstructured":"Dyall SC. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front Aging Neurosci. 2015;7:52.","journal-title":"Front Aging Neurosci"},{"key":"803_CR30","unstructured":"Ronald L, Schnaar RS, Michael Tiemeyer, and Taroh Kinoshita. In: Varki A CR, Esko JD, Essentials of Glycobiology [Internet] 4th edition, Cold et al. Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 2022."},{"key":"803_CR31","doi-asserted-by":"publisher","first-page":"572965","DOI":"10.3389\/fnins.2020.572965","volume":"14","author":"S Sipione","year":"2020","unstructured":"Sipione S, Monyror J, Galleguillos D, Steinberg N, Kadam V. Gangliosides in the brain: physiology, pathophysiology and therapeutic applications. Front Neurosci. 2020;14:572965.","journal-title":"Front Neurosci"},{"issue":"1","key":"803_CR32","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1038\/s41467-024-48734-y","volume":"15","author":"M Osetrova","year":"2024","unstructured":"Osetrova M, Tkachev A, Mair W, Guijarro Larraz P, Efimova O, Kurochkin I, et al. Lipidome atlas of the adult human brain. Nat Commun. 2024;15(1):4455.","journal-title":"Nat Commun"},{"issue":"8","key":"803_CR33","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.bbalip.2010.05.004","volume":"1801","author":"P Foley","year":"2010","unstructured":"Foley P. Lipids in Alzheimer\u2019s disease: a century-old story. Biochim Biophys Acta. 2010;1801(8):750\u20133.","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"803_CR34","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1038\/s41588-022-01024-z","volume":"54","author":"C Bellenguez","year":"2022","unstructured":"Bellenguez C, Kucukali F, Jansen IE, Kleineidam L, Moreno-Grau S, Amin N, et al. New insights into the genetic etiology of Alzheimer\u2019s disease and related dementias. Nat Genet. 2022;54(4):412\u201336.","journal-title":"Nat Genet"},{"issue":"1","key":"803_CR35","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1038\/s41467-021-22491-8","volume":"12","author":"I de Rojas","year":"2021","unstructured":"de Rojas I, Moreno-Grau S, Tesi N, Grenier-Boley B, Andrade V, Jansen IE, et al. Common variants in Alzheimer\u2019s disease and risk stratification by polygenic risk scores. Nat Commun. 2021;12(1):3417.","journal-title":"Nat Commun"},{"issue":"8006","key":"803_CR36","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/s41586-024-07185-7","volume":"628","author":"MS Haney","year":"2024","unstructured":"Haney MS, Palovics R, Munson CN, Long C, Johansson PK, Yip O, et al. APOE4\/4 is linked to damaging lipid droplets in Alzheimer\u2019s disease microglia. Nature. 2024;628(8006):154\u201361.","journal-title":"Nature"},{"issue":"6","key":"803_CR37","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/febs.16344","volume":"290","author":"F Yin","year":"2023","unstructured":"Yin F. Lipid metabolism and Alzheimer\u2019s disease: clinical evidence, mechanistic link and therapeutic promise. FEBS J. 2023;290(6):1420\u201353.","journal-title":"FEBS J"},{"key":"803_CR38","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fnagi.2015.00119","volume":"7","author":"P Gamba","year":"2015","unstructured":"Gamba P, Testa G, Gargiulo S, Staurenghi E, Poli G, Leonarduzzi G. Oxidized cholesterol as the driving force behind the development of Alzheimer\u2019s disease. Front Aging Neurosci. 2015;7:119.","journal-title":"Front Aging Neurosci"},{"issue":"6534","key":"803_CR39","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/375754a0","volume":"375","author":"R Sherrington","year":"1995","unstructured":"Sherrington R, Rogaev EI, Liang Y, Rogaeva EA, Levesque G, Ikeda M, et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer\u2019s disease. Nature. 1995;375(6534):754\u201360.","journal-title":"Nature"},{"issue":"5028","key":"803_CR40","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.1925564","volume":"254","author":"J Murrell","year":"1991","unstructured":"Murrell J, Farlow M, Ghetti B, Benson MD. A mutation in the amyloid precursor protein associated with hereditary Alzheimer\u2019s disease. Science. 1991;254(5028):97\u20139.","journal-title":"Science"},{"issue":"6347","key":"803_CR41","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/353844a0","volume":"353","author":"MC Chartier-Harlin","year":"1991","unstructured":"Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, et al. Early-onset Alzheimer\u2019s disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature. 1991;353(6347):844\u20136.","journal-title":"Nature"},{"issue":"6311","key":"803_CR42","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1038\/349704a0","volume":"349","author":"A Goate","year":"1991","unstructured":"Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer\u2019s disease. Nature. 1991;349(6311):704\u20136.","journal-title":"Nature"},{"issue":"5","key":"803_CR43","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, et al. Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A. 1993;90(5):1977\u201381.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"803_CR44","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","volume":"15","author":"Y Yamazaki","year":"2019","unstructured":"Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u201318.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"803_CR45","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1194\/jlr.R075408","volume":"58","author":"GW Rebeck","year":"2017","unstructured":"Rebeck GW. The role of APOE on lipid homeostasis and inflammation in normal brains. J Lipid Res. 2017;58(8):1493\u20139.","journal-title":"J Lipid Res"},{"issue":"10","key":"803_CR46","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/ng.440","volume":"41","author":"D Harold","year":"2009","unstructured":"Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease. Nat Genet. 2009;41(10):1088\u201393.","journal-title":"Nat Genet"},{"issue":"11","key":"803_CR47","doi-asserted-by":"publisher","first-page":"e13950","DOI":"10.1371\/journal.pone.0013950","volume":"5","author":"L Jones","year":"2010","unstructured":"Jones L, Holmans PA, Hamshere ML, Harold D, Moskvina V, Ivanov D, et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer\u2019s disease. PLoS ONE. 2010;5(11):e13950.","journal-title":"PLoS ONE"},{"issue":"6","key":"803_CR48","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","volume":"160","author":"Y Wang","year":"2015","unstructured":"Wang Y, Cella M, Mallinson K, Ulrich JD, Young KL, Robinette ML, et al. TREM2 lipid sensing sustains the microglial response in an Alzheimer\u2019s disease model. Cell. 2015;160(6):1061\u201371.","journal-title":"Cell"},{"issue":"9","key":"803_CR49","doi-asserted-by":"publisher","first-page":"113129","DOI":"10.1016\/j.celrep.2023.113129","volume":"42","author":"P Preman","year":"2023","unstructured":"Preman P, Arranz AM. A neuron-specific interaction between Alzheimer\u2019s disease risk factors SORL1, APOE, and CLU. Cell Rep. 2023;42(9):113129.","journal-title":"Cell Rep"},{"issue":"2","key":"803_CR50","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1161\/ATVBAHA.108.179283","volume":"30","author":"L Yvan-Charvet","year":"2010","unstructured":"Yvan-Charvet L, Wang N, Tall AR. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol. 2010;30(2):139\u201343.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"13","key":"803_CR51","doi-asserted-by":"publisher","first-page":"3848","DOI":"10.1523\/JNEUROSCI.3757-15.2016","volume":"36","author":"N Sakae","year":"2016","unstructured":"Sakae N, Liu CC, Shinohara M, Frisch-Daiello J, Ma L, Yamazaki Y, et al. ABCA7 Deficiency accelerates amyloid-beta generation and Alzheimer\u2019s neuronal Pathology. J Neurosci. 2016;36(13):3848\u201359.","journal-title":"J Neurosci"},{"issue":"3","key":"803_CR52","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41380-023-02372-w","volume":"29","author":"K Kawatani","year":"2024","unstructured":"Kawatani K, Holm ML, Starling SC, Martens YA, Zhao J, Lu W, et al. ABCA7 deficiency causes neuronal dysregulation by altering mitochondrial lipid metabolism. Mol Psychiatry. 2024;29(3):809\u201319.","journal-title":"Mol Psychiatry"},{"issue":"25","key":"803_CR53","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.7150\/jca.31254","volume":"10","author":"L Li","year":"2019","unstructured":"Li L, Hua L, Fan H, He Y, Xu W, Zhang L, et al. Interplay of PKD3 with SREBP1 promotes cell growth via upregulating lipogenesis in prostate Cancer cells. J Cancer. 2019;10(25):6395\u2013404.","journal-title":"J Cancer"},{"issue":"11","key":"803_CR54","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1136\/gutjnl-2020-321774","volume":"70","author":"N Sun","year":"2021","unstructured":"Sun N, Shen C, Zhang L, Wu X, Yu Y, Yang X, et al. Hepatic kruppel-like factor 16 (KLF16) targets PPARalpha to improve steatohepatitis and insulin resistance. Gut. 2021;70(11):2183\u201395.","journal-title":"Gut"},{"issue":"3","key":"803_CR55","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1152\/physrev.00028.2012","volume":"93","author":"T Balla","year":"2013","unstructured":"Balla T. Phosphoinositides: tiny lipids with giant impact on cell regulation. Physiol Rev. 2013;93(3):1019\u2013137.","journal-title":"Physiol Rev"},{"issue":"1","key":"803_CR56","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13195-019-0469-0","volume":"11","author":"L Magno","year":"2019","unstructured":"Magno L, Lessard CB, Martins M, Lang V, Cruz P, Asi Y, et al. Alzheimer\u2019s disease phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. Alzheimers Res Ther. 2019;11(1):16.","journal-title":"Alzheimers Res Ther"},{"issue":"17","key":"803_CR57","doi-asserted-by":"publisher","first-page":"e105603","DOI":"10.15252\/embj.2020105603","volume":"40","author":"E Maguire","year":"2021","unstructured":"Maguire E, Menzies GE, Phillips T, Sasner M, Williams HM, Czubala MA, et al. PIP2 depletion and altered endocytosis caused by expression of Alzheimer\u2019s disease-protective variant PLCgamma2 R522. EMBO J. 2021;40(17):e105603.","journal-title":"EMBO J"},{"issue":"8","key":"803_CR58","doi-asserted-by":"publisher","first-page":"105022","DOI":"10.1016\/j.jbc.2023.105022","volume":"299","author":"GL Waddell","year":"2023","unstructured":"Waddell GL, Drew EE, Rupp HP, Hansen SD. Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase. J Biol Chem. 2023;299(8):105022.","journal-title":"J Biol Chem"},{"key":"803_CR59","doi-asserted-by":"crossref","unstructured":"Schneider N, Hauser J, Oliveira M, Cazaubon E, Mottaz SC, O\u2019Neill BV et al. Sphingomyelin in Brain and Cognitive Development: Preliminary Data. eNeuro 2019;6(4).","DOI":"10.1523\/ENEURO.0421-18.2019"},{"issue":"1","key":"803_CR60","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1172\/JCI29154","volume":"117","author":"JM MacArthur","year":"2007","unstructured":"MacArthur JM, Bishop JR, Stanford KI, Wang L, Bensadoun A, Witztum JL, et al. Liver heparan sulfate proteoglycans mediate clearance of triglyceride-rich lipoproteins independently of LDL receptor family members. J Clin Invest. 2007;117(1):153\u201364.","journal-title":"J Clin Invest"},{"issue":"1","key":"803_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-2275(20)33334-4","volume":"40","author":"RW Mahley","year":"1999","unstructured":"Mahley RW, Ji ZS. Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res. 1999;40(1):1\u201316.","journal-title":"J Lipid Res"},{"issue":"6","key":"803_CR62","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.cmet.2018.04.015","volume":"27","author":"PJ White","year":"2018","unstructured":"White PJ, McGarrah RW, Grimsrud PA, Tso SC, Yang WH, Haldeman JM, et al. The BCKDH kinase and Phosphatase Integrate BCAA and lipid metabolism via regulation of ATP-Citrate lyase. Cell Metab. 2018;27(6):1281\u201393. e7.","journal-title":"Cell Metab"},{"key":"803_CR63","doi-asserted-by":"crossref","unstructured":"Gao H, Guo Y, Yan Q, Yang W, Li R, Lin S et al. Lipoatrophy and metabolic disturbance in mice with adipose-specific deletion of kindlin-2. JCI Insight 2019;4(13).","DOI":"10.1172\/jci.insight.128405"},{"issue":"11","key":"803_CR64","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1038\/cdd.2016.66","volume":"23","author":"SZ Chen","year":"2016","unstructured":"Chen SZ, Ning LF, Xu X, Jiang WY, Xing C, Jia WP, et al. The miR-181d-regulated metalloproteinase Adamts1 enzymatically impairs adipogenesis via ECM remodeling. Cell Death Differ. 2016;23(11):1778\u201391.","journal-title":"Cell Death Differ"},{"issue":"8","key":"803_CR65","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","volume":"43","author":"AM Saunders","year":"1993","unstructured":"Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop PH, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer\u2019s disease. Neurology. 1993;43(8):1467\u201372.","journal-title":"Neurology"},{"key":"803_CR66","unstructured":"Huang Y, Mahley RW, Apolipoprotein E, Pt. 3\u201312."},{"issue":"4852","key":"803_CR67","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1126\/science.3283935","volume":"240","author":"RW Mahley","year":"1988","unstructured":"Mahley RW, Apolipoprotein E. Cholesterol transport protein with expanding role in cell biology. Science. 1988;240(4852):622\u201330.","journal-title":"Science"},{"issue":"26","key":"803_CR68","doi-asserted-by":"publisher","first-page":"23742","DOI":"10.1074\/jbc.M102348200","volume":"276","author":"N Wang","year":"2001","unstructured":"Wang N, Silver DL, Thiele C, Tall AR. ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem. 2001;276(26):23742\u20137.","journal-title":"J Biol Chem"},{"issue":"3","key":"803_CR69","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s44161-022-00022-y","volume":"1","author":"Y Sun","year":"2022","unstructured":"Sun Y, Li X. Cholesterol efflux mechanism revealed by structural analysis of human ABCA1 conformational states. Nat Cardiovasc Res. 2022;1(3):238\u201345.","journal-title":"Nat Cardiovasc Res"},{"issue":"5","key":"803_CR70","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/ng.803","volume":"43","author":"P Hollingworth","year":"2011","unstructured":"Hollingworth P, Harold D, Sims R, Gerrish A, Lambert JC, Carrasquillo MM, et al. Common variants at ABCA7, MS4A6A\/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer\u2019s disease. Nat Genet. 2011;43(5):429\u201335.","journal-title":"Nat Genet"},{"issue":"44","key":"803_CR71","doi-asserted-by":"publisher","first-page":"42906","DOI":"10.1074\/jbc.M307831200","volume":"278","author":"N Wang","year":"2003","unstructured":"Wang N, Lan D, Gerbod-Giannone M, Linsel-Nitschke P, Jehle AW, Chen W, et al. ATP-binding cassette transporter A7 (ABCA7) binds apolipoprotein A-I and mediates cellular phospholipid but not cholesterol efflux. J Biol Chem. 2003;278(44):42906\u201312.","journal-title":"J Biol Chem"},{"key":"803_CR72","doi-asserted-by":"crossref","unstructured":"von Maydell D, Wright S, Bonner JM, Staab C, Spitaleri A, Liu L et al. Single-cell atlas of ABCA7 loss-of-function reveals impaired neuronal respiration via choline-dependent lipid imbalances. bioRxiv. 2024.","DOI":"10.1101\/2023.09.05.556135"},{"issue":"2","key":"803_CR73","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/ng1943","volume":"39","author":"E Rogaeva","year":"2007","unstructured":"Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, et al. The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease. Nat Genet. 2007;39(2):168\u201377.","journal-title":"Nat Genet"},{"issue":"37","key":"803_CR74","doi-asserted-by":"publisher","first-page":"e2408262121","DOI":"10.1073\/pnas.2408262121","volume":"121","author":"AMG Jensen","year":"2024","unstructured":"Jensen AMG, Raska J, Fojtik P, Monti G, Lunding M, Bartova S, et al. The SORL1 p.Y1816C variant causes impaired endosomal dimerization and autosomal dominant Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2024;121(37):e2408262121.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"803_CR75","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1097\/MOL.0000000000000598","volume":"30","author":"DM Conlon","year":"2019","unstructured":"Conlon DM. Role of sortilin in lipid metabolism. Curr Opin Lipidol. 2019;30(3):198\u2013204.","journal-title":"Curr Opin Lipidol"},{"key":"803_CR76","doi-asserted-by":"crossref","unstructured":"Asaro A, Sinha R, Bakun M, Kalnytska O, Carlo-Spiewok AS, Rubel T et al. ApoE4 disrupts interaction of sortilin with fatty acid-binding protein 7 essential to promote lipid signaling. J Cell Sci 2021;134(20).","DOI":"10.1242\/jcs.258894"},{"issue":"1","key":"803_CR77","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s13195-022-01119-z","volume":"14","author":"YA Ko","year":"2022","unstructured":"Ko YA, Billheimer JT, Lyssenko NN, Kueider-Paisley A, Wolk DA, Arnold SE, et al. ApoJ\/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer\u2019s disease. Alzheimers Res Ther. 2022;14(1):194.","journal-title":"Alzheimers Res Ther"},{"issue":"4","key":"803_CR78","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3390\/pathophysiology31040040","volume":"31","author":"A Laslo","year":"2024","unstructured":"Laslo A, Laslo L, Arbanasi EM, Ujlaki-Nagi AA, Chinezu L, Ivanescu AD, et al. Pathways to Alzheimer\u2019s Disease: the intersecting roles of Clusterin and apolipoprotein E in amyloid-beta regulation and neuronal health. Pathophysiology. 2024;31(4):545\u201358.","journal-title":"Pathophysiology"},{"issue":"2","key":"803_CR79","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327.","journal-title":"N Engl J Med"},{"issue":"2","key":"803_CR80","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, et al. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):107\u201316.","journal-title":"N Engl J Med"},{"issue":"9","key":"803_CR81","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/s41577-023-00837-1","volume":"23","author":"M Colonna","year":"2023","unstructured":"Colonna M. The biology of TREM receptors. Nat Rev Immunol. 2023;23(9):580\u201394.","journal-title":"Nat Rev Immunol"},{"key":"803_CR82","doi-asserted-by":"crossref","unstructured":"Gouna G, Klose C, Bosch-Queralt M, Liu L, Gokce O, Schifferer M et al. TREM2-dependent lipid droplet biogenesis in phagocytes is required for remyelination. J Exp Med 2021;218(10).","DOI":"10.1084\/jem.20210227"},{"issue":"5","key":"803_CR83","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.neuron.2019.12.007","volume":"105","author":"AA Nugent","year":"2020","unstructured":"Nugent AA, Lin K, van Lengerich B, Lianoglou S, Przybyla L, Davis SS, et al. TREM2 regulates microglial cholesterol metabolism upon chronic phagocytic challenge. Neuron. 2020;105(5):837\u201354. e9.","journal-title":"Neuron"},{"key":"803_CR84","doi-asserted-by":"publisher","first-page":"115962","DOI":"10.1016\/j.biopha.2023.115962","volume":"170","author":"W Wei","year":"2024","unstructured":"Wei W, Zhang L, Xin W, Pan Y, Tatenhorst L, Hao Z, et al. TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury. Biomed Pharmacother. 2024;170:115962.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"803_CR85","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/ng.3916","volume":"49","author":"R Sims","year":"2017","unstructured":"Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J, et al. Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer\u2019s disease. Nat Genet. 2017;49(9):1373\u201384.","journal-title":"Nat Genet"},{"issue":"2","key":"803_CR86","doi-asserted-by":"publisher","first-page":"100905","DOI":"10.1016\/j.jbc.2021.100905","volume":"297","author":"JT Jackson","year":"2021","unstructured":"Jackson JT, Mulazzani E, Nutt SL, Masters SL. The role of PLCgamma2 in immunological disorders, cancer, and neurodegeneration. J Biol Chem. 2021;297(2):100905.","journal-title":"J Biol Chem"},{"issue":"12","key":"803_CR87","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/ng.2802","volume":"45","author":"JC Lambert","year":"2013","unstructured":"Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer\u2019s disease. Nat Genet. 2013;45(12):1452\u20138.","journal-title":"Nat Genet"},{"issue":"11","key":"803_CR88","doi-asserted-by":"publisher","first-page":"4908","DOI":"10.1002\/alz.13089","volume":"19","author":"JD Samuels","year":"2023","unstructured":"Samuels JD, Moore KA, Ennerfelt HE, Johnson AM, Walsh AE, Price RJ, et al. The Alzheimer\u2019s disease risk factor INPP5D restricts neuroprotective microglial responses in amyloid beta-mediated pathology. Alzheimers Dement. 2023;19(11):4908\u201321.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"803_CR89","doi-asserted-by":"publisher","first-page":"119653","DOI":"10.1016\/j.bbamcr.2023.119653","volume":"1871","author":"M Wit","year":"2024","unstructured":"Wit M, Belykh A, Sumara G. Protein kinase D (PKD) on the crossroad of lipid absorption, synthesis and utilization. Biochim Biophys Acta Mol Cell Res. 2024;1871(2):119653.","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"20","key":"803_CR90","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.1016\/j.yexcr.2006.08.027","volume":"312","author":"E Tellier","year":"2006","unstructured":"Tellier E, Canault M, Rebsomen L, Bonardo B, Juhan-Vague I, Nalbone G, et al. The shedding activity of ADAM17 is sequestered in lipid rafts. Exp Cell Res. 2006;312(20):3969\u201380.","journal-title":"Exp Cell Res"},{"issue":"6","key":"803_CR91","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1161\/ATVBAHA.121.315145","volume":"41","author":"V Kothari","year":"2021","unstructured":"Kothari V, Tang J, He Y, Kramer F, Kanter JE, Bornfeldt KE. ADAM17 boosts cholesterol efflux and downstream effects of High-Density Lipoprotein on Inflammatory pathways in Macrophages. Arterioscler Thromb Vasc Biol. 2021;41(6):1854\u201373.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"803_CR92","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1476-511X-4-2","volume":"4","author":"LC Wilsie","year":"2005","unstructured":"Wilsie LC, Chanchani S, Navaratna D, Orlando RA. Cell surface heparan sulfate proteoglycans contribute to intracellular lipid accumulation in adipocytes. Lipids Health Dis. 2005;4:2.","journal-title":"Lipids Health Dis"},{"key":"803_CR93","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s42003-018-0262-9","volume":"2","author":"Y Wei","year":"2019","unstructured":"Wei Y, Xiong ZJ, Li J, Zou C, Cairo CW, Klassen JS, et al. Crystal structures of human lysosomal EPDR1 reveal homology with the superfamily of bacterial lipoprotein transporters. Commun Biol. 2019;2:52.","journal-title":"Commun Biol"},{"issue":"5","key":"803_CR94","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.cmet.2019.10.001","volume":"30","author":"AS Deshmukh","year":"2019","unstructured":"Deshmukh AS, Peijs L, Beaudry JL, Jespersen NZ, Nielsen CH, Ma T, et al. Proteomics-based comparative mapping of the secretomes of Human Brown and White adipocytes reveals EPDR1 as a Novel Batokine. Cell Metab. 2019;30(5):963\u201375. e7.","journal-title":"Cell Metab"},{"key":"803_CR95","unstructured":"Kozlova A, Zhang S, Sudwarts A, Zhang H, Smirnou S, Sun X et al. Alzheimer\u2019s disease risk allele of PICALM causes detrimental lipid droplets in microglia. Res Sq 2024."},{"issue":"7","key":"803_CR96","doi-asserted-by":"publisher","first-page":"167","DOI":"10.15698\/cst2020.07.225","volume":"4","author":"S Hernandez-Diaz","year":"2020","unstructured":"Hernandez-Diaz S, Soukup SF. The role of lipids in autophagy and its implication in neurodegeneration. Cell Stress. 2020;4(7):167\u201386.","journal-title":"Cell Stress"},{"issue":"5506","key":"803_CR97","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1126\/science.291.5506.1051","volume":"291","author":"MG Ford","year":"2001","unstructured":"Ford MG, Pearse BM, Higgins MK, Vallis Y, Owen DJ, Gibson A, et al. Simultaneous binding of PtdIns(4,5)P2 and clathrin by AP180 in the nucleation of clathrin lattices on membranes. Science. 2001;291(5506):1051\u20135.","journal-title":"Science"},{"issue":"20","key":"803_CR98","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1093\/hmg\/ddae115","volume":"33","author":"M Paveskovic","year":"2024","unstructured":"Paveskovic M, De-Paula RB, Ojelade SA, Tantry EK, Kochukov MY, Bao S, et al. Alzheimer\u2019s disease risk gene CD2AP is a dose-sensitive determinant of synaptic structure and plasticity. Hum Mol Genet. 2024;33(20):1815\u201332.","journal-title":"Hum Mol Genet"},{"issue":"12","key":"803_CR99","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1038\/ncb1986","volume":"11","author":"S Pant","year":"2009","unstructured":"Pant S, Sharma M, Patel K, Caplan S, Carr CM, Grant BD. AMPH-1\/Amphiphysin\/Bin1 functions with RME-1\/Ehd1 in endocytic recycling. Nat Cell Biol. 2009;11(12):1399\u2013410.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"803_CR100","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/j.bbalip.2010.04.005","volume":"1801","author":"L Jones","year":"2010","unstructured":"Jones L, Harold D, Williams J. Genetic evidence for the involvement of lipid metabolism in Alzheimer\u2019s disease. Biochim Biophys Acta. 2010;1801(8):754\u201361.","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"803_CR101","doi-asserted-by":"publisher","first-page":"e0162238","DOI":"10.1371\/journal.pone.0162238","volume":"11","author":"MK Jang","year":"2016","unstructured":"Jang MK, Lee S, Jung MH. RNA-Seq analysis reveals a negative role of KLF16 in Adipogenesis. PLoS ONE. 2016;11(9):e0162238.","journal-title":"PLoS ONE"},{"issue":"9\u201310","key":"803_CR102","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1101\/gad.310490.117","volume":"32","author":"M Kim","year":"2018","unstructured":"Kim M, Wende H, Walcher J, Kuhnemund J, Cheret C, Kempa S, et al. Maf links Neuregulin1 signaling to cholesterol synthesis in myelinating Schwann cells. Genes Dev. 2018;32(9\u201310):645\u201357.","journal-title":"Genes Dev"},{"issue":"6","key":"803_CR103","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1194\/jlr.R300004-JLR200","volume":"44","author":"X Han","year":"2003","unstructured":"Han X, Gross RW. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics. J Lipid Res. 2003;44(6):1071\u20139.","journal-title":"J Lipid Res"},{"key":"803_CR104","doi-asserted-by":"crossref","unstructured":"Yang K, Han X, Lipidomics. Techniques, applications, and outcomes related to Biomedical sciences. Trends Biochem Sci. 2016;41(11):954\u201369.","DOI":"10.1016\/j.tibs.2016.08.010"},{"issue":"1","key":"803_CR105","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0021-9258(18)64849-5","volume":"226","author":"J Folch","year":"1957","unstructured":"Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem. 1957;226(1):497\u2013509.","journal-title":"J Biol Chem"},{"issue":"8","key":"803_CR106","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1139\/o59-099","volume":"37","author":"EG Bligh","year":"1959","unstructured":"Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37(8):911\u20137.","journal-title":"Can J Biochem Physiol"},{"key":"803_CR107","doi-asserted-by":"crossref","unstructured":"Breil C, Abert Vian M, Zemb T, Kunz W, Chemat F. Bligh and Dyer and Folch methods for solid-liquid-liquid extraction of lipids from microorganisms. Comprehension of Solvatation mechanisms and towards substitution with alternative solvents. Int J Mol Sci 2017;18(4).","DOI":"10.3390\/ijms18040708"},{"issue":"5","key":"803_CR108","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1194\/jlr.D700041-JLR200","volume":"49","author":"V Matyash","year":"2008","unstructured":"Matyash V, Liebisch G, Kurzchalia TV, Shevchenko A, Schwudke D. Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics. J Lipid Res. 2008;49(5):1137\u201346.","journal-title":"J Lipid Res"},{"issue":"8","key":"803_CR109","doi-asserted-by":"publisher","first-page":"1690","DOI":"10.1194\/jlr.D023036","volume":"53","author":"L Lofgren","year":"2012","unstructured":"Lofgren L, Stahlman M, Forsberg GB, Saarinen S, Nilsson R, Hansson GI. The BUME method: a novel automated chloroform-free 96-well total lipid extraction method for blood plasma. J Lipid Res. 2012;53(8):1690\u2013700.","journal-title":"J Lipid Res"},{"issue":"3","key":"803_CR110","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1002\/mas.20023","volume":"24","author":"X Han","year":"2005","unstructured":"Han X, Gross RW. Shotgun lipidomics: electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples. Mass Spectrom Rev. 2005;24(3):367\u2013412.","journal-title":"Mass Spectrom Rev"},{"issue":"12","key":"803_CR111","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1042\/bj0351358","volume":"35","author":"AJ Martin","year":"1941","unstructured":"Martin AJ, Synge RL. A new form of chromatogram employing two liquid phases: a theory of chromatography. 2. Application to the micro-determination of the higher monoamino-acids in proteins. Biochem J. 1941;35(12):1358\u201368.","journal-title":"Biochem J"},{"issue":"12","key":"803_CR112","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1021\/ac60256a003","volume":"39","author":"CG Horvath","year":"1967","unstructured":"Horvath CG, Preiss BA, Lipsky SR. Fast liquid chromatography: an investigation of operating parameters and the separation of nucleotides on pellicular ion exchangers. Anal Chem. 1967;39(12):1422\u20138.","journal-title":"Anal Chem"},{"key":"803_CR113","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0021-9673(00)96972-3","volume":"499","author":"AJ Alpert","year":"1990","unstructured":"Alpert AJ. Hydrophilic-interaction chromatography for the separation of peptides, nucleic acids and other polar compounds. J Chromatogr. 1990;499:177\u201396.","journal-title":"J Chromatogr"},{"issue":"4926","key":"803_CR114","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1126\/science.2675315","volume":"246","author":"JB Fenn","year":"1989","unstructured":"Fenn JB, Mann M, Meng CK, Wong SF, Whitehouse CM. Electrospray ionization for mass spectrometry of large biomolecules. Science. 1989;246(4926):64\u201371.","journal-title":"Science"},{"issue":"15","key":"803_CR115","doi-asserted-by":"publisher","first-page":"3653","DOI":"10.1021\/ac0001636","volume":"72","author":"DB Robb","year":"2000","unstructured":"Robb DB, Covey TR, Bruins AP. Atmospheric pressure photoionization: an ionization method for liquid chromatography-mass spectrometry. Anal Chem. 2000;72(15):3653\u20139.","journal-title":"Anal Chem"},{"issue":"24","key":"803_CR116","doi-asserted-by":"publisher","first-page":"A1193","DOI":"10.1021\/ac00024a716","volume":"63","author":"F Hillenkamp","year":"1991","unstructured":"Hillenkamp F, Karas M, Beavis RC, Chait BT. Matrix-assisted laser desorption\/ionization mass spectrometry of biopolymers. Anal Chem. 1991;63(24):A1193\u2013203.","journal-title":"Anal Chem"},{"issue":"5695","key":"803_CR117","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1126\/science.1104404","volume":"306","author":"Z Takats","year":"2004","unstructured":"Takats Z, Wiseman JM, Gologan B, Cooks RG. Mass spectrometry sampling under ambient conditions with desorption electrospray ionization. Science. 2004;306(5695):471\u20133.","journal-title":"Science"},{"issue":"1","key":"803_CR118","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1021\/ac403554h","volume":"86","author":"M Li","year":"2014","unstructured":"Li M, Yang L, Bai Y, Liu H. Analytical methods in lipidomics and their applications. Anal Chem. 2014;86(1):161\u201375.","journal-title":"Anal Chem"},{"issue":"1","key":"803_CR119","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1146\/annurev-anchem-091619-103512","volume":"13","author":"S Samfors","year":"2020","unstructured":"Samfors S, Fletcher JS. Lipid diversity in cells and tissue using imaging SIMS. Annu Rev Anal Chem (Palo Alto Calif). 2020;13(1):249\u201371.","journal-title":"Annu Rev Anal Chem (Palo Alto Calif)"},{"issue":"1","key":"803_CR120","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1006\/abio.2001.5178","volume":"295","author":"X Han","year":"2001","unstructured":"Han X, Gross RW. Quantitative analysis and molecular species fingerprinting of triacylglyceride molecular species directly from lipid extracts of biological samples by electrospray ionization tandem mass spectrometry. Anal Biochem. 2001;295(1):88\u2013100.","journal-title":"Anal Biochem"},{"key":"803_CR121","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.plipres.2015.12.002","volume":"61","author":"M Wang","year":"2016","unstructured":"Wang M, Wang C, Han RH, Han X. Novel advances in shotgun lipidomics for biology and medicine. Prog Lipid Res. 2016;61:83\u2013108.","journal-title":"Prog Lipid Res"},{"issue":"2","key":"803_CR122","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.jasms.2005.11.003","volume":"17","author":"X Han","year":"2006","unstructured":"Han X, Yang K, Yang J, Fikes KN, Cheng H, Gross RW. Factors influencing the electrospray intrasource separation and selective ionization of glycerophospholipids. J Am Soc Mass Spectrom. 2006;17(2):264\u201374.","journal-title":"J Am Soc Mass Spectrom"},{"key":"803_CR123","doi-asserted-by":"crossref","unstructured":"Jennifer L, Johnson LAJ. Homeostasis of lipid metabolism in disorders of the brain. 2021.","DOI":"10.1016\/B978-0-12-819641-0.00146-8"},{"issue":"11","key":"803_CR124","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1016\/j.bbamem.2009.08.016","volume":"1788","author":"J Fantini","year":"2009","unstructured":"Fantini J, Barrantes FJ. Sphingolipid\/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim Biophys Acta. 2009;1788(11):2345\u201361.","journal-title":"Biochim Biophys Acta"},{"key":"803_CR125","doi-asserted-by":"crossref","unstructured":"Codini M, Garcia-Gil M, Albi E. Cholesterol and sphingolipid enriched lipid rafts as therapeutic targets in Cancer. Int J Mol Sci 2021;22(2).","DOI":"10.3390\/ijms22020726"},{"issue":"5","key":"803_CR126","doi-asserted-by":"publisher","first-page":"3501","DOI":"10.1007\/s12035-018-1286-3","volume":"56","author":"H Jesko","year":"2019","unstructured":"Jesko H, Stepien A, Lukiw WJ, Strosznajder RP. The Cross-talk between sphingolipids and insulin-like growth factor signaling: significance for aging and neurodegeneration. Mol Neurobiol. 2019;56(5):3501\u201321.","journal-title":"Mol Neurobiol"},{"issue":"8","key":"803_CR127","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","volume":"56","author":"K Czubowicz","year":"2019","unstructured":"Czubowicz K, Jesko H, Wencel P, Lukiw WJ, Strosznajder RP. The role of Ceramide and Sphingosine-1-Phosphate in Alzheimer\u2019s Disease and Other Neurodegenerative disorders. Mol Neurobiol. 2019;56(8):5436\u201355.","journal-title":"Mol Neurobiol"},{"key":"803_CR128","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.addr.2019.12.003","volume":"159","author":"SM Crivelli","year":"2020","unstructured":"Crivelli SM, Giovagnoni C, Visseren L, Scheithauer AL, de Wit N, den Hoedt S, et al. Sphingolipids in Alzheimer\u2019s disease, how can we target them? Adv Drug Deliv Rev. 2020;159:214\u201331.","journal-title":"Adv Drug Deliv Rev"},{"key":"803_CR129","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.neurobiolaging.2016.03.027","volume":"43","author":"TA Couttas","year":"2016","unstructured":"Couttas TA, Kain N, Suchowerska AK, Quek LE, Turner N, Fath T, et al. Loss of ceramide synthase 2 activity, necessary for myelin biosynthesis, precedes tau pathology in the cortical pathogenesis of Alzheimer\u2019s disease. Neurobiol Aging. 2016;43:89\u2013100.","journal-title":"Neurobiol Aging"},{"key":"803_CR130","doi-asserted-by":"crossref","unstructured":"Olsen ASB, Faergeman NJ. Sphingolipids: membrane microdomains in brain development, function and neurological diseases. Open Biol 2017;7(5).","DOI":"10.1098\/rsob.170069"},{"issue":"4","key":"803_CR131","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1046\/j.1471-4159.2002.00997.x","volume":"82","author":"X Han","year":"2002","unstructured":"Han X, D MH, McKeel DW Jr., Kelley J, Morris JC. Substantial sulfatide deficiency and ceramide elevation in very early Alzheimer\u2019s disease: potential role in disease pathogenesis. J Neurochem. 2002;82(4):809\u201318.","journal-title":"J Neurochem"},{"issue":"3","key":"803_CR132","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.neurobiolaging.2008.05.010","volume":"31","author":"X He","year":"2010","unstructured":"He X, Huang Y, Li B, Gong CX, Schuchman EH. Deregulation of sphingolipid metabolism in Alzheimer\u2019s disease. Neurobiol Aging. 2010;31(3):398\u2013408.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"803_CR133","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.jalz.2010.03.014","volume":"6","author":"MM Mielke","year":"2010","unstructured":"Mielke MM, Haughey NJ, Bandaru VV, Schech S, Carrick R, Carlson MC, et al. Plasma ceramides are altered in mild cognitive impairment and predict cognitive decline and hippocampal volume loss. Alzheimers Dement. 2010;6(5):378\u201385.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"803_CR134","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3233\/JAD-2011-111202","volume":"29","author":"V Filippov","year":"2012","unstructured":"Filippov V, Song MA, Zhang K, Vinters HV, Tung S, Kirsch WM, et al. Increased ceramide in brains with Alzheimer\u2019s and other neurodegenerative diseases. J Alzheimers Dis. 2012;29(3):537\u201347.","journal-title":"J Alzheimers Dis"},{"issue":"7","key":"803_CR135","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1111\/jnc.16042","volume":"168","author":"HX Huang","year":"2024","unstructured":"Huang HX, Inglese P, Tang J, Yagoubi R, Correia GDS, Horneffer-van der Sluis VM, et al. Mass spectrometry imaging highlights dynamic patterns of lipid co-expression with Abeta plaques in mouse and human brains. J Neurochem. 2024;168(7):1193\u2013214.","journal-title":"J Neurochem"},{"key":"803_CR136","doi-asserted-by":"crossref","unstructured":"Akyol S, Ugur Z, Yilmaz A, Ustun I, Gorti SKK, Oh K et al. Lipid Profiling of Alzheimer\u2019s Disease Brain Highlights Enrichment in Glycerol(phospho)lipid, and Sphingolipid Metabolism. Cells 2021;10(10).","DOI":"10.3390\/cells10102591"},{"issue":"4","key":"803_CR137","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.neurobiolaging.2007.07.024","volume":"30","author":"VV Bandaru","year":"2009","unstructured":"Bandaru VV, Troncoso J, Wheeler D, Pletnikova O, Wang J, Conant K, et al. ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer\u2019s but not normal brain. Neurobiol Aging. 2009;30(4):591\u20139.","journal-title":"Neurobiol Aging"},{"issue":"7","key":"803_CR138","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1073\/pnas.0305799101","volume":"101","author":"RG Cutler","year":"2004","unstructured":"Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K, et al. Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2004;101(7):2070\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4\u20135","key":"803_CR139","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s11064-007-9297-x","volume":"32","author":"P Katsel","year":"2007","unstructured":"Katsel P, Li C, Haroutunian V. Gene expression alterations in the sphingolipid metabolism pathways during progression of dementia and Alzheimer\u2019s disease: a shift toward ceramide accumulation at the earliest recognizable stages of Alzheimer\u2019s disease? Neurochem Res. 2007;32(4\u20135):845\u201356.","journal-title":"Neurochem Res"},{"issue":"7","key":"803_CR140","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1023\/A:1011603916962","volume":"26","author":"JW Pettegrew","year":"2001","unstructured":"Pettegrew JW, Panchalingam K, Hamilton RL, McClure RJ. Brain membrane phospholipid alterations in Alzheimer\u2019s disease. Neurochem Res. 2001;26(7):771\u201382.","journal-title":"Neurochem Res"},{"issue":"1","key":"803_CR141","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/s42003-022-04011-6","volume":"5","author":"P Baloni","year":"2022","unstructured":"Baloni P, Arnold M, Buitrago L, Nho K, Moreno H, Huynh K, et al. Multi-omic analyses characterize the ceramide\/sphingomyelin pathway as a therapeutic target in Alzheimer\u2019s disease. Commun Biol. 2022;5(1):1074.","journal-title":"Commun Biol"},{"issue":"5","key":"803_CR142","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/j.bbalip.2013.08.002","volume":"1841","author":"K Yuyama","year":"2014","unstructured":"Yuyama K, Mitsutake S, Igarashi Y. Pathological roles of ceramide and its metabolites in metabolic syndrome and Alzheimer\u2019s disease. Biochim Biophys Acta. 2014;1841(5):793\u20138.","journal-title":"Biochim Biophys Acta"},{"issue":"12","key":"803_CR143","doi-asserted-by":"publisher","first-page":"3489","DOI":"10.1111\/j.1460-9568.2004.03852.x","volume":"20","author":"Y Huang","year":"2004","unstructured":"Huang Y, Tanimukai H, Liu F, Iqbal K, Grundke-Iqbal I, Gong CX. Elevation of the level and activity of acid ceramidase in Alzheimer\u2019s disease brain. Eur J Neurosci. 2004;20(12):3489\u201397.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"803_CR144","doi-asserted-by":"publisher","first-page":"70","DOI":"10.5114\/fn.2014.41745","volume":"52","author":"H Jesko","year":"2014","unstructured":"Jesko H, Okada T, Strosznajder RP, Nakamura S. Sphingosine kinases modulate the secretion of amyloid beta precursor protein from SH-SY5Y neuroblastoma cells: the role of alpha-synuclein. Folia Neuropathol. 2014;52(1):70\u20138.","journal-title":"Folia Neuropathol"},{"key":"803_CR145","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2051-5960-2-9","volume":"2","author":"TA Couttas","year":"2014","unstructured":"Couttas TA, Kain N, Daniels B, Lim XY, Shepherd C, Kril J, et al. Loss of the neuroprotective factor sphingosine 1-phosphate early in Alzheimer\u2019s disease pathogenesis. Acta Neuropathol Commun. 2014;2:9.","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"803_CR146","doi-asserted-by":"publisher","first-page":"158630","DOI":"10.1016\/j.bbalip.2020.158630","volume":"1865","author":"N Presa","year":"2020","unstructured":"Presa N, Gomez-Larrauri A, Dominguez-Herrera A, Trueba M, Gomez-Munoz A. Novel signaling aspects of ceramide 1-phosphate. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(4):158630.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"803_CR147","doi-asserted-by":"publisher","first-page":"1368839","DOI":"10.3389\/fnagi.2024.1368839","volume":"16","author":"B Uranbileg","year":"2024","unstructured":"Uranbileg B, Isago H, Sakai E, Kubota M, Saito Y, Kurano M. Alzheimer\u2019s disease manifests abnormal sphingolipid metabolism. Front Aging Neurosci. 2024;16:1368839.","journal-title":"Front Aging Neurosci"},{"issue":"3","key":"803_CR148","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1046\/j.1471-4159.1994.62031039.x","volume":"62","author":"L Svennerholm","year":"1994","unstructured":"Svennerholm L, Gottfries CG. Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II). J Neurochem. 1994;62(3):1039\u201347.","journal-title":"J Neurochem"},{"issue":"1","key":"803_CR149","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1042\/BJ20110566","volume":"438","author":"L Hejazi","year":"2011","unstructured":"Hejazi L, Wong JW, Cheng D, Proschogo N, Ebrahimi D, Garner B, et al. Mass and relative elution time profiling: two-dimensional analysis of sphingolipids in Alzheimer\u2019s disease brains. Biochem J. 2011;438(1):165\u201375.","journal-title":"Biochem J"},{"issue":"10","key":"803_CR150","doi-asserted-by":"publisher","first-page":"537","DOI":"10.5650\/jos.60.537","volume":"60","author":"RK Yu","year":"2011","unstructured":"Yu RK, Tsai YT, Ariga T, Yanagisawa M. Structures, biosynthesis, and functions of gangliosides\u2013an overview. J Oleo Sci. 2011;60(10):537\u201344.","journal-title":"J Oleo Sci"},{"issue":"11","key":"803_CR151","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/j.neurobiolaging.2007.12.022","volume":"30","author":"A Bernardo","year":"2009","unstructured":"Bernardo A, Harrison FE, McCord M, Zhao J, Bruchey A, Davies SS, et al. Elimination of GD3 synthase improves memory and reduces amyloid-beta plaque load in transgenic mice. Neurobiol Aging. 2009;30(11):1777\u201391.","journal-title":"Neurobiol Aging"},{"issue":"10","key":"803_CR152","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1248\/bpb.b12-00400","volume":"35","author":"T Taki","year":"2012","unstructured":"Taki T. An approach to glycobiology from glycolipidomics: ganglioside molecular scanning in the brains of patients with Alzheimer\u2019s disease by TLC-blot\/matrix assisted laser desorption\/ionization-time of flight MS. Biol Pharm Bull. 2012;35(10):1642\u20137.","journal-title":"Biol Pharm Bull"},{"issue":"3","key":"803_CR153","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/0197-0186(92)90058-Y","volume":"20","author":"I Kracun","year":"1992","unstructured":"Kracun I, Kalanj S, Talan-Hranilovic J, Cosovic C. Cortical distribution of gangliosides in Alzheimer\u2019s disease. Neurochem Int. 1992;20(3):433\u20138.","journal-title":"Neurochem Int"},{"issue":"2\u20133","key":"803_CR154","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s12035-008-8022-3","volume":"37","author":"M Eckhardt","year":"2008","unstructured":"Eckhardt M. The role and metabolism of sulfatide in the nervous system. Mol Neurobiol. 2008;37(2\u20133):93\u2013103.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"803_CR155","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF02641017","volume":"43","author":"PJ Stoffyn","year":"1966","unstructured":"Stoffyn PJ. The structure and chemistry of sulfatides. J Am Oil Chem Soc. 1966;43(2):69\u201374.","journal-title":"J Am Oil Chem Soc"},{"issue":"8","key":"803_CR156","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/glycob\/cwj122","volume":"16","author":"M Kyogashima","year":"2006","unstructured":"Kyogashima M, Tamiya-Koizumi K, Ehara T, Li G, Hu R, Hara A, et al. Rapid demonstration of diversity of sulfatide molecular species from biological materials by MALDI-TOF MS. Glycobiology. 2006;16(8):719\u201328.","journal-title":"Glycobiology"},{"issue":"8","key":"803_CR157","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1194\/jlr.R026682","volume":"53","author":"T Takahashi","year":"2012","unstructured":"Takahashi T, Suzuki T. Role of sulfatide in normal and pathological cells and tissues. J Lipid Res. 2012;53(8):1437\u201350.","journal-title":"J Lipid Res"},{"issue":"2","key":"803_CR158","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0022-2275(20)43122-0","volume":"9","author":"L Svennerholm","year":"1968","unstructured":"Svennerholm L, Stallberg-Stenhagen S. Changes in the fatty acid composition of cerebrosides and sulfatides of human nervous tissue with age. J Lipid Res. 1968;9(2):215\u201325.","journal-title":"J Lipid Res"},{"issue":"5","key":"803_CR159","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0197-4580(86)90160-0","volume":"7","author":"LB Torello","year":"1986","unstructured":"Torello LB, Yates AJ, Hart R, Leon KS. A comparative-evolutionary study of lipids in the aging brain of mice. Neurobiol Aging. 1986;7(5):337\u201346.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"803_CR160","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1471-4159.2007.04708.x","volume":"103","author":"X Han","year":"2007","unstructured":"Han X. Potential mechanisms contributing to sulfatide depletion at the earliest clinically recognizable stage of Alzheimer\u2019s disease: a tale of shotgun lipidomics. J Neurochem. 2007;103(1):171\u20139.","journal-title":"J Neurochem"},{"issue":"6","key":"803_CR161","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1111\/jnc.12368","volume":"127","author":"H Cheng","year":"2013","unstructured":"Cheng H, Wang M, Li JL, Cairns NJ, Han X. Specific changes of sulfatide levels in individuals with pre-clinical Alzheimer\u2019s disease: an early event in disease pathogenesis. J Neurochem. 2013;127(6):733\u20138.","journal-title":"J Neurochem"},{"issue":"9 Pt B","key":"803_CR162","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.bbamem.2017.05.009","volume":"1859","author":"E Gonzalez de San Roman","year":"2017","unstructured":"Gonzalez de San Roman E, Manuel I, Giralt MT, Ferrer I, Rodriguez-Puertas R. Imaging mass spectrometry (IMS) of cortical lipids from preclinical to severe stages of Alzheimer\u2019s disease. Biochim Biophys Acta Biomembr. 2017;1859(9 Pt B):1604\u201314.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"2","key":"803_CR163","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.chembiol.2023.10.021","volume":"31","author":"VC Zimmer","year":"2024","unstructured":"Zimmer VC, Lauer AA, Haupenthal V, Stahlmann CP, Mett J, Grosgen S, et al. A bidirectional link between sulfatide and Alzheimer\u2019s disease. Cell Chem Biol. 2024;31(2):265\u201383. e7.","journal-title":"Cell Chem Biol"},{"key":"803_CR164","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neuroscience.2011.07.045","volume":"193","author":"D Yuki","year":"2011","unstructured":"Yuki D, Sugiura Y, Zaima N, Akatsu H, Hashizume Y, Yamamoto T, et al. Hydroxylated and non-hydroxylated sulfatide are distinctly distributed in the human cerebral cortex. Neuroscience. 2011;193:44\u201353.","journal-title":"Neuroscience"},{"issue":"12","key":"803_CR165","doi-asserted-by":"publisher","first-page":"e23225","DOI":"10.1016\/j.neurobiolaging.2010.05.019","volume":"32","author":"CE Sexton","year":"2011","unstructured":"Sexton CE, Kalu UG, Filippini N, Mackay CE, Ebmeier KP. A meta-analysis of diffusion tensor imaging in mild cognitive impairment and Alzheimer\u2019s disease. Neurobiol Aging. 2011;32(12):e23225\u201318.","journal-title":"Neurobiol Aging"},{"issue":"8","key":"803_CR166","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1002\/alz.13057","volume":"19","author":"A Garnier-Crussard","year":"2023","unstructured":"Garnier-Crussard A, Cotton F, Krolak-Salmon P, Chetelat G. White matter hyperintensities in Alzheimer\u2019s disease: beyond vascular contribution. Alzheimers Dement. 2023;19(8):3738\u201348.","journal-title":"Alzheimers Dement"},{"issue":"16\u201318","key":"803_CR167","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1089\/ars.2024.0676","volume":"41","author":"Z Xu","year":"2024","unstructured":"Xu Z, He S, Begum MM, Han X. Myelin lipid alterations in neurodegenerative diseases: Landscape and pathogenic implications. Antioxid Redox Signal. 2024;41(16\u201318):1073\u201399.","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"803_CR168","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/S1388-1981(99)00201-2","volume":"1484","author":"BN Marbois","year":"2000","unstructured":"Marbois BN, Faull KF, Fluharty AL, Raval-Fernandes S, Rome LH. Analysis of sulfatide from rat cerebellum and multiple sclerosis white matter by negative ion electrospray mass spectrometry. Biochim Biophys Acta. 2000;1484(1):59\u201370.","journal-title":"Biochim Biophys Acta"},{"key":"803_CR169","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.aca.2016.11.054","volume":"951","author":"M Pintado-Sierra","year":"2017","unstructured":"Pintado-Sierra M, Garcia-Alvarez I, Bribian A, Medina-Rodriguez EM, Lebron-Aguilar R, Garrido L, et al. A comprehensive profiling of sulfatides in myelin from mouse brain using liquid chromatography coupled to high-resolution accurate tandem mass spectrometry. Anal Chim Acta. 2017;951:89\u201398.","journal-title":"Anal Chim Acta"},{"issue":"7","key":"803_CR170","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1194\/jlr.D076588","volume":"58","author":"M Blomqvist","year":"2017","unstructured":"Blomqvist M, Boren J, Zetterberg H, Blennow K, Mansson JE, Stahlman M. High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS\/MS. J Lipid Res. 2017;58(7):1482\u20139.","journal-title":"J Lipid Res"},{"issue":"3","key":"803_CR171","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1582-4934.2001.tb00159.x","volume":"5","author":"A Cedazo-Minguez","year":"2001","unstructured":"Cedazo-Minguez A, Cowburn RF. Apolipoprotein E: a major piece in the Alzheimer\u2019s disease puzzle. J Cell Mol Med. 2001;5(3):254\u201366.","journal-title":"J Cell Mol Med"},{"issue":"10","key":"803_CR172","doi-asserted-by":"publisher","first-page":"8043","DOI":"10.1074\/jbc.M212340200","volume":"278","author":"X Han","year":"2003","unstructured":"Han X, Cheng H, Fryer JD, Fagan AM, Holtzman DM. Novel role for apolipoprotein E in the central nervous system. Modulation of sulfatide content. J Biol Chem. 2003;278(10):8043\u201351.","journal-title":"J Biol Chem"},{"issue":"7","key":"803_CR173","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1016\/j.neurobiolaging.2008.07.020","volume":"31","author":"H Cheng","year":"2010","unstructured":"Cheng H, Zhou Y, Holtzman DM, Han X. Apolipoprotein E mediates sulfatide depletion in animal models of Alzheimer\u2019s disease. Neurobiol Aging. 2010;31(7):1188\u201396.","journal-title":"Neurobiol Aging"},{"issue":"2\u20133","key":"803_CR174","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12035-009-8092-x","volume":"41","author":"X Han","year":"2010","unstructured":"Han X. The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer\u2019s disease. Mol Neurobiol. 2010;41(2\u20133):97\u2013106.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"803_CR175","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13024-021-00488-7","volume":"16","author":"S Qiu","year":"2021","unstructured":"Qiu S, Palavicini JP, Wang J, Gonzalez NS, He S, Dustin E, et al. Adult-onset CNS myelin sulfatide deficiency is sufficient to cause Alzheimer\u2019s disease-like neuroinflammation and cognitive impairment. Mol Neurodegener. 2021;16(1):64.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"803_CR176","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0092-8674(00)80093-8","volume":"86","author":"T Coetzee","year":"1996","unstructured":"Coetzee T, Fujita N, Dupree J, Shi R, Blight A, Suzuki K, et al. Myelination in the absence of galactocerebroside and sulfatide: normal structure with abnormal function and regional instability. Cell. 1996;86(2):209\u201319.","journal-title":"Cell"},{"issue":"1","key":"803_CR177","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/jnc.13738","volume":"139","author":"JP Palavicini","year":"2016","unstructured":"Palavicini JP, Wang C, Chen L, Ahmar S, Higuera JD, Dupree JL, et al. Novel molecular insights into the critical role of sulfatide in myelin maintenance\/function. J Neurochem. 2016;139(1):40\u201354.","journal-title":"J Neurochem"},{"issue":"4","key":"803_CR178","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/glia.20292","volume":"53","author":"J Marcus","year":"2006","unstructured":"Marcus J, Honigbaum S, Shroff S, Honke K, Rosenbluth J, Dupree JL. Sulfatide is essential for the maintenance of CNS myelin and axon structure. Glia. 2006;53(4):372\u201381.","journal-title":"Glia"},{"issue":"7","key":"803_CR179","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1002\/glia.21172","volume":"59","author":"KA Potter","year":"2011","unstructured":"Potter KA, Kern MJ, Fullbright G, Bielawski J, Scherer SS, Yum SW, et al. Central nervous system dysfunction in a mouse model of FA2H deficiency. Glia. 2011;59(7):1009\u201321.","journal-title":"Glia"},{"issue":"9","key":"803_CR180","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1002\/glia.24423","volume":"71","author":"E Dustin","year":"2023","unstructured":"Dustin E, McQuiston AR, Honke K, Palavicini JP, Han X, Dupree JL. Adult-onset depletion of sulfatide leads to axonal degeneration with relative myelin sparing. Glia. 2023;71(9):2285\u2013303.","journal-title":"Glia"},{"issue":"1","key":"803_CR181","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/WAD.0b013e318032d2b1","volume":"21","author":"OT Carmichael","year":"2007","unstructured":"Carmichael OT, Kuller LH, Lopez OL, Thompson PM, Dutton RA, Lu A, et al. Cerebral ventricular changes associated with transitions between normal cognitive function, mild cognitive impairment, and dementia. Alzheimer Dis Assoc Disord. 2007;21(1):14\u201324.","journal-title":"Alzheimer Dis Assoc Disord"},{"issue":"Pt 9","key":"803_CR182","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1093\/brain\/awn146","volume":"131","author":"SM Nestor","year":"2008","unstructured":"Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, et al. Ventricular enlargement as a possible measure of Alzheimer\u2019s disease progression validated using the Alzheimer\u2019s disease neuroimaging initiative database. Brain. 2008;131(Pt 9):2443\u201354.","journal-title":"Brain"},{"key":"803_CR183","doi-asserted-by":"crossref","unstructured":"Palavicini JP, Ding L, Pan M, Qiu S, Wang H, Shen Q et al. Sulfatide Deficiency, an Early Alzheimer\u2019s Lipidomic Signature, Causes Brain Ventricular Enlargement in the Absence of Classical Neuropathological Hallmarks. Int J Mol Sci 2022;24(1).","DOI":"10.3390\/ijms24010233"},{"issue":"9","key":"803_CR184","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.bbadis.2014.04.012","volume":"1842","author":"JK Morris","year":"2014","unstructured":"Morris JK, Honea RA, Vidoni ED, Swerdlow RH, Burns JM. Is Alzheimer\u2019s disease a systemic disease? Biochim Biophys Acta. 2014;1842(9):1340\u20139.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"803_CR185","doi-asserted-by":"publisher","first-page":"e1332","DOI":"10.1002\/ctm2.1332","volume":"13","author":"S He","year":"2023","unstructured":"He S, Qiu S, Pan M, Palavicini JP, Wang H, Li X, et al. Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer\u2019s disease. Clin Transl Med. 2023;13(7):e1332.","journal-title":"Clin Transl Med"},{"issue":"4","key":"803_CR186","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/j.1468-1331.2008.02503.x","volume":"16","author":"HR Brunnstrom","year":"2009","unstructured":"Brunnstrom HR, Englund EM. Cause of death in patients with dementia disorders. Eur J Neurol. 2009;16(4):488\u201392.","journal-title":"Eur J Neurol"},{"key":"803_CR187","doi-asserted-by":"crossref","unstructured":"Flores-Cordero JA, Perez-Perez A, Jimenez-Cortegana C, Alba G, Flores-Barragan A, Sanchez-Margalet V. Obesity as a Risk Factor for Dementia and Alzheimer\u2019s Disease: The Role of Leptin. Int J Mol Sci 2022;23(9).","DOI":"10.3390\/ijms23095202"},{"issue":"11","key":"803_CR188","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1113\/EP087862","volume":"104","author":"CL Tsai","year":"2019","unstructured":"Tsai CL, Pan CY, Chen FC, Huang TH, Tsai MC, Chuang CY. Differences in neurocognitive performance and metabolic and inflammatory indices in male adults with obesity as a function of regular exercise. Exp Physiol. 2019;104(11):1650\u201360.","journal-title":"Exp Physiol"},{"issue":"8","key":"803_CR189","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1016\/j.neurobiolaging.2014.02.010","volume":"35","author":"EM Knight","year":"2014","unstructured":"Knight EM, Martins IV, Gumusgoz S, Allan SM, Lawrence CB. High-fat diet-induced memory impairment in triple-transgenic Alzheimer\u2019s disease (3xTgAD) mice is independent of changes in amyloid and tau pathology. Neurobiol Aging. 2014;35(8):1821\u201332.","journal-title":"Neurobiol Aging"},{"key":"803_CR190","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1172\/jci.insight.137286","volume":"5","author":"JP Palavicini","year":"2020","unstructured":"Palavicini JP, Chen J, Wang C, Wang J, Qin C, Baeuerle E, et al. Early disruption of nerve mitochondrial and myelin lipid homeostasis in obesity-induced diabetes. JCI Insight. 2020;5:21.","journal-title":"JCI Insight"},{"issue":"4","key":"803_CR191","doi-asserted-by":"publisher","first-page":"519","DOI":"10.3803\/EnM.2016.31.4.519","volume":"31","author":"E Roh","year":"2016","unstructured":"Roh E, Kim MS. Brain regulation of Energy Metabolism. Endocrinol Metab (Seoul). 2016;31(4):519\u201324.","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"12","key":"803_CR192","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.tem.2023.08.014","volume":"34","author":"A Furlan","year":"2023","unstructured":"Furlan A, Petrus P. Brain-body communication in metabolic control. Trends Endocrinol Metab. 2023;34(12):813\u201322.","journal-title":"Trends Endocrinol Metab"},{"key":"803_CR193","doi-asserted-by":"crossref","unstructured":"Qiu S, He S, Wang J, Wang H, Bhattacharjee A, Li X et al. Adult-onset CNS Sulfatide Deficiency causes sex-dependent metabolic disruption in aging. Int J Mol Sci 2023;24(13).","DOI":"10.3390\/ijms241310483"},{"issue":"Pt 4","key":"803_CR194","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1242\/jcs.060681","volume":"123","author":"A Linetti","year":"2010","unstructured":"Linetti A, Fratangeli A, Taverna E, Valnegri P, Francolini M, Cappello V, et al. Cholesterol reduction impairs exocytosis of synaptic vesicles. J Cell Sci. 2010;123(Pt 4):595\u2013605.","journal-title":"J Cell Sci"},{"issue":"8","key":"803_CR195","doi-asserted-by":"publisher","first-page":"158706","DOI":"10.1016\/j.bbalip.2020.158706","volume":"1865","author":"F Zakany","year":"2020","unstructured":"Zakany F, Kovacs T, Panyi G, Varga Z. Direct and indirect cholesterol effects on membrane proteins with special focus on potassium channels. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(8):158706.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"6478","key":"803_CR196","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1126\/science.aaz2288","volume":"367","author":"C Wang","year":"2020","unstructured":"Wang C, Yue H, Hu Z, Shen Y, Ma J, Li J, et al. Microglia mediate forgetting via complement-dependent synaptic elimination. Science. 2020;367(6478):688\u201394.","journal-title":"Science"},{"issue":"29","key":"803_CR197","doi-asserted-by":"publisher","first-page":"7628","DOI":"10.1523\/JNEUROSCI.0726-16.2016","volume":"36","author":"ES Mathews","year":"2016","unstructured":"Mathews ES, Appel B. Cholesterol biosynthesis supports myelin gene expression and Axon Ensheathment through Modulation of P13K\/Akt\/mTor signaling. J Neurosci. 2016;36(29):7628\u201339.","journal-title":"J Neurosci"},{"issue":"4","key":"803_CR198","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/nn1426","volume":"8","author":"G Saher","year":"2005","unstructured":"Saher G, Brugger B, Lappe-Siefke C, Mobius W, Tozawa R, Wehr MC, et al. High cholesterol level is essential for myelin membrane growth. Nat Neurosci. 2005;8(4):468\u201375.","journal-title":"Nat Neurosci"},{"issue":"4","key":"803_CR199","doi-asserted-by":"publisher","first-page":"891","DOI":"10.3233\/JAD-2012-121585","volume":"33","author":"TM Hughes","year":"2013","unstructured":"Hughes TM, Rosano C, Evans RW, Kuller LH. Brain cholesterol metabolism, oxysterols, and dementia. J Alzheimers Dis. 2013;33(4):891\u2013911.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"803_CR200","doi-asserted-by":"publisher","first-page":"100350","DOI":"10.1016\/j.jlr.2023.100350","volume":"64","author":"AG Cashikar","year":"2023","unstructured":"Cashikar AG, Toral-Rios D, Timm D, Romero J, Strickland M, Long JM, et al. Regulation of astrocyte lipid metabolism and ApoE secretionby the microglial oxysterol, 25-hydroxycholesterol. J Lipid Res. 2023;64(4):100350.","journal-title":"J Lipid Res"},{"issue":"3","key":"803_CR201","doi-asserted-by":"publisher","first-page":"a006312","DOI":"10.1101\/cshperspect.a006312","volume":"2","author":"DM Holtzman","year":"2012","unstructured":"Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(3):a006312.","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"9","key":"803_CR202","doi-asserted-by":"publisher","first-page":"e30523","DOI":"10.1016\/j.heliyon.2024.e30523","volume":"10","author":"LC Liu","year":"2024","unstructured":"Liu LC, Liang JY, Liu YH, Liu B, Dong XH, Cai WH, et al. The intersection of cerebral cholesterol metabolism and Alzheimer\u2019s disease: mechanisms and therapeutic prospects. Heliyon. 2024;10(9):e30523.","journal-title":"Heliyon"},{"issue":"5","key":"803_CR203","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/nrn3012","volume":"12","author":"G Di Paolo","year":"2011","unstructured":"Di Paolo G, Kim TW. Linking lipids to Alzheimer\u2019s disease: cholesterol and beyond. Nat Rev Neurosci. 2011;12(5):284\u201396.","journal-title":"Nat Rev Neurosci"},{"issue":"11","key":"803_CR204","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1021\/cn300077c","volume":"3","author":"AH Abuznait","year":"2012","unstructured":"Abuznait AH, Kaddoumi A. Role of ABC transporters in the pathogenesis of Alzheimer\u2019s disease. ACS Chem Neurosci. 2012;3(11):820\u201331.","journal-title":"ACS Chem Neurosci"},{"key":"803_CR205","doi-asserted-by":"crossref","unstructured":"Staurenghi E, Giannelli S, Testa G, Sottero B, Leonarduzzi G, Gamba P. Cholesterol Dysmetabolism in Alzheimer\u2019s Disease: A Starring Role for Astrocytes? Antioxid (Basel) 2021;10(12).","DOI":"10.3390\/antiox10121890"},{"issue":"4Supplementary","key":"803_CR206","first-page":"1577","volume":"34","author":"M Rizwan","year":"2021","unstructured":"Rizwan M, Aslam N, Ashfaq UA, Hayat M, Hussain SM. SNP of HMGCR and apo E genes and their impact in response to statin therapy in hypercholesterolemic and hypertriglyceridemic patients in Pakistan. Pak J Pharm Sci. 2021;34(4Supplementary):1577\u201383.","journal-title":"Pak J Pharm Sci"},{"issue":"1","key":"803_CR207","doi-asserted-by":"publisher","first-page":"159069","DOI":"10.1016\/j.bbalip.2021.159069","volume":"1867","author":"S Azizidoost","year":"2022","unstructured":"Azizidoost S, Babaahmadi-Rezaei H, Nazeri Z, Cheraghzadeh M, Kheirollah A. Amyloid beta increases ABCA1 and HMGCR protein expression, and cholesterol synthesis and accumulation in mice neurons and astrocytes. Biochim Biophys Acta Mol Cell Biol Lipids. 2022;1867(1):159069.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"4","key":"803_CR208","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/nn0403-345","volume":"6","author":"L Puglielli","year":"2003","unstructured":"Puglielli L, Tanzi RE, Kovacs DM. Alzheimer\u2019s disease: the cholesterol connection. Nat Neurosci. 2003;6(4):345\u201351.","journal-title":"Nat Neurosci"},{"issue":"5","key":"803_CR209","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1093\/brain\/awae028","volume":"147","author":"H Ahmed","year":"2024","unstructured":"Ahmed H, Wang Y, Griffiths WJ, Levey AI, Pikuleva I, Liang SH, et al. Brain cholesterol and Alzheimer\u2019s disease: challenges and opportunities in probe and drug development. Brain. 2024;147(5):1622\u201335.","journal-title":"Brain"},{"issue":"5","key":"803_CR210","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1073\/pnas.89.5.1671","volume":"89","author":"RM Nitsch","year":"1992","unstructured":"Nitsch RM, Blusztajn JK, Pittas AG, Slack BE, Growdon JH, Wurtman RJ. Evidence for a membrane defect in Alzheimer disease brain. Proc Natl Acad Sci U S A. 1992;89(5):1671\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"803_CR211","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-3084(00)00128-6","volume":"106","author":"AA Farooqui","year":"2000","unstructured":"Farooqui AA, Horrocks LA, Farooqui T. Glycerophospholipids in brain: their metabolism, incorporation into membranes, functions, and involvement in neurological disorders. Chem Phys Lipids. 2000;106(1):1\u201329.","journal-title":"Chem Phys Lipids"},{"issue":"4","key":"803_CR212","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1023\/A:1027380331807","volume":"22","author":"AA Farooqui","year":"1997","unstructured":"Farooqui AA, Rapoport SI, Horrocks LA. Membrane phospholipid alterations in Alzheimer\u2019s disease: deficiency of ethanolamine plasmalogens. Neurochem Res. 1997;22(4):523\u20137.","journal-title":"Neurochem Res"},{"issue":"2","key":"803_CR213","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/(SICI)1098-1136(199908)27:2<110::AID-GLIA2>3.0.CO;2-C","volume":"27","author":"D Stephenson","year":"1999","unstructured":"Stephenson D, Rash K, Smalstig B, Roberts E, Johnstone E, Sharp J, et al. Cytosolic phospholipase A2 is induced in reactive glia following different forms of neurodegeneration. Glia. 1999;27(2):110\u201328.","journal-title":"Glia"},{"issue":"5","key":"803_CR214","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s11064-006-9061-7","volume":"31","author":"B Kuczynski","year":"2006","unstructured":"Kuczynski B, Reo NV. Evidence that plasmalogen is protective against oxidative stress in the rat brain. Neurochem Res. 2006;31(5):639\u201356.","journal-title":"Neurochem Res"},{"issue":"7","key":"803_CR215","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1097\/00005072-199907000-00008","volume":"58","author":"Z Guan","year":"1999","unstructured":"Guan Z, Wang Y, Cairns NJ, Lantos PL, Dallner G, Sindelar PJ. Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease. J Neuropathol Exp Neurol. 1999;58(7):740\u20137.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"803_CR216","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1046\/j.1471-4159.2001.00332.x","volume":"77","author":"X Han","year":"2001","unstructured":"Han X, Holtzman DM, McKeel DW. Jr. Plasmalogen deficiency in early Alzheimer\u2019s disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry. J Neurochem. 2001;77(4):1168\u201380.","journal-title":"J Neurochem"},{"issue":"3","key":"803_CR217","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s00401-011-0836-9","volume":"122","author":"J Kou","year":"2011","unstructured":"Kou J, Kovacs GG, Hoftberger R, Kulik W, Brodde A, Forss-Petter S, et al. Peroxisomal alterations in Alzheimer\u2019s disease. Acta Neuropathol. 2011;122(3):271\u201383.","journal-title":"Acta Neuropathol"},{"key":"803_CR218","doi-asserted-by":"publisher","first-page":"1443536","DOI":"10.3389\/fcell.2024.1443536","volume":"12","author":"MS Hossain","year":"2024","unstructured":"Hossain MS, Mawatari S, Honsho M, Okauchi T, Fujino T. KIT-13, a novel plasmalogen derivative, attenuates neuroinflammation and amplifies cognition. Front Cell Dev Biol. 2024;12:1443536.","journal-title":"Front Cell Dev Biol"},{"key":"803_CR219","doi-asserted-by":"publisher","first-page":"148790","DOI":"10.1016\/j.brainres.2024.148790","volume":"1828","author":"Y Zhai","year":"2024","unstructured":"Zhai Y, Morihara R, Feng T, Hu X, Fukui Y, Bian Z, et al. Protective effect of scallop-derived plasmalogen against vascular dysfunction, via the pSTAT3\/PIM1\/NFATc1 axis, in a novel mouse model of Alzheimer\u2019s disease with cerebral hypoperfusion. Brain Res. 2024;1828:148790.","journal-title":"Brain Res"},{"key":"803_CR220","doi-asserted-by":"publisher","first-page":"149132","DOI":"10.1016\/j.brainres.2024.149132","volume":"1843","author":"T Smith","year":"2024","unstructured":"Smith T, Knudsen KJ, Ritchie SA. A novel inducible animal model for studying chronic plasmalogen deficiency associated with Alzheimer\u2019s disease. Brain Res. 2024;1843:149132.","journal-title":"Brain Res"},{"issue":"2","key":"803_CR221","doi-asserted-by":"publisher","first-page":"e23428","DOI":"10.1096\/fj.202301976R","volume":"38","author":"A Hamu-Tanoue","year":"2024","unstructured":"Hamu-Tanoue A, Takagi K, Taketomi Y, Miki Y, Nishito Y, Kano K, et al. Group III secreted phospholipase A(2) -driven lysophospholipid pathway protects against allergic asthma. FASEB J. 2024;38(2):e23428.","journal-title":"FASEB J"},{"key":"803_CR222","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.redox.2017.04.030","volume":"12","author":"C Hu","year":"2017","unstructured":"Hu C, Wang M, Han X. Shotgun lipidomics in substantiating lipid peroxidation in redox biology: methods and applications. Redox Biol. 2017;12:946\u201355.","journal-title":"Redox Biol"},{"issue":"4","key":"803_CR223","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.plipres.2011.06.001","volume":"50","author":"V Frisardi","year":"2011","unstructured":"Frisardi V, Panza F, Seripa D, Farooqui T, Farooqui AA. Glycerophospholipids and glycerophospholipid-derived lipid mediators: a complex meshwork in Alzheimer\u2019s disease pathology. Prog Lipid Res. 2011;50(4):313\u201330.","journal-title":"Prog Lipid Res"},{"key":"803_CR224","doi-asserted-by":"publisher","first-page":"1066578","DOI":"10.3389\/fnagi.2022.1066578","volume":"14","author":"M Kurano","year":"2022","unstructured":"Kurano M, Saito Y, Uranbileg B, Saigusa D, Kano K, Aoki J, et al. Modulations of bioactive lipids and their receptors in postmortem Alzheimer\u2019s disease brains. Front Aging Neurosci. 2022;14:1066578.","journal-title":"Front Aging Neurosci"},{"issue":"49","key":"803_CR225","doi-asserted-by":"publisher","first-page":"20936","DOI":"10.1073\/pnas.0905654106","volume":"106","author":"SD Ryan","year":"2009","unstructured":"Ryan SD, Whitehead SN, Swayne LA, Moffat TC, Hou W, Ethier M, et al. Amyloid-beta42 signals tau hyperphosphorylation and compromises neuronal viability by disrupting alkylacylglycerophosphocholine metabolism. Proc Natl Acad Sci U S A. 2009;106(49):20936\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"803_CR226","doi-asserted-by":"publisher","first-page":"165797","DOI":"10.1016\/j.bbadis.2020.165797","volume":"1866","author":"AM Sabogal-Guaqueta","year":"2020","unstructured":"Sabogal-Guaqueta AM, Arias-Londono JD, Gutierrez-Vargas J, Sepulveda-Falla D, Glatzel M, Villegas-Lanau A, et al. Common disbalance in the brain parenchyma of dementias: phospholipid profile analysis between CADASIL and sporadic Alzheimer\u2019s disease. Biochim Biophys Acta Mol Basis Dis. 2020;1866(8):165797.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"4","key":"803_CR227","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.3233\/JAD-215448","volume":"86","author":"K Kalecky","year":"2022","unstructured":"Kalecky K, German DC, Montillo AA, Bottiglieri T. Targeted metabolomic analysis in Alzheimer\u2019s Disease plasma and brain tissue in non-hispanic whites. J Alzheimers Dis. 2022;86(4):1875\u201395.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"803_CR228","doi-asserted-by":"publisher","first-page":"349","DOI":"10.37349\/ent.2024.00088","volume":"4","author":"E Birgbauer","year":"2024","unstructured":"Birgbauer E. Lysophospholipid receptors in neurodegeneration and neuroprotection. Explor Neuroprotective Ther. 2024;4(4):349\u201365.","journal-title":"Explor Neuroprotective Ther"},{"key":"803_CR229","doi-asserted-by":"crossref","unstructured":"Gomes R, Mendes I, Duarte MP, Bandarra NM, Gomes-Bispo A. New forms of neuroactive phospholipids for DHA Enrichment in Brain. Mar Drugs 2024;22(3).","DOI":"10.3390\/md22030116"},{"issue":"2","key":"803_CR230","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41593-019-0566-1","volume":"23","author":"J Marschallinger","year":"2020","unstructured":"Marschallinger J, Iram T, Zardeneta M, Lee SE, Lehallier B, Haney MS, et al. Lipid-droplet-accumulating microglia represent a dysfunctional and proinflammatory state in the aging brain. Nat Neurosci. 2020;23(2):194\u2013208.","journal-title":"Nat Neurosci"},{"issue":"6","key":"803_CR231","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.cmet.2024.03.014","volume":"36","author":"Y Li","year":"2024","unstructured":"Li Y, Munoz-Mayorga D, Nie Y, Kang N, Tao Y, Lagerwall J, et al. Microglial lipid droplet accumulation in tauopathy brain is regulated by neuronal AMPK. Cell Metab. 2024;36(6):1351\u2013e708.","journal-title":"Cell Metab"},{"key":"803_CR232","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.neuroscience.2024.04.014","volume":"549","author":"K Mallick","year":"2024","unstructured":"Mallick K, Paul S, Banerjee S, Banerjee S. Lipid droplets and neurodegeneration. Neuroscience. 2024;549:13\u201323.","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"803_CR233","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.cell.2014.12.019","volume":"160","author":"L Liu","year":"2015","unstructured":"Liu L, Zhang K, Sandoval H, Yamamoto S, Jaiswal M, Sanz E, et al. Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell. 2015;160(1\u20132):177\u201390.","journal-title":"Cell"},{"issue":"8","key":"803_CR234","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/s41574-023-00845-0","volume":"19","author":"A Zadoorian","year":"2023","unstructured":"Zadoorian A, Du X, Yang H. Lipid droplet biogenesis and functions in health and disease. Nat Rev Endocrinol. 2023;19(8):443\u201359.","journal-title":"Nat Rev Endocrinol"},{"issue":"1\u20134","key":"803_CR235","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000535131","volume":"9","author":"X Zhao","year":"2023","unstructured":"Zhao X, Zhang S, Sanders AR, Duan J. Brain lipids and lipid droplet dysregulation in Alzheimer\u2019s Disease and Neuropsychiatric disorders. Complex Psychiatry. 2023;9(1\u20134):154\u201371.","journal-title":"Complex Psychiatry"},{"key":"803_CR236","doi-asserted-by":"publisher","first-page":"746749","DOI":"10.3389\/fphys.2021.746749","volume":"12","author":"W Zhang","year":"2021","unstructured":"Zhang W, Xu L, Zhu L, Liu Y, Yang S, Zhao M. Lipid droplets, the Central Hub Integrating Cell Metabolism and the Immune System. Front Physiol. 2021;12:746749.","journal-title":"Front Physiol"},{"issue":"1","key":"803_CR237","doi-asserted-by":"publisher","first-page":"108572","DOI":"10.1016\/j.celrep.2020.108572","volume":"34","author":"G Qi","year":"2021","unstructured":"Qi G, Mi Y, Shi X, Gu H, Brinton RD, Yin F. ApoE4 impairs neuron-astrocyte coupling of fatty acid metabolism. Cell Rep. 2021;34(1):108572.","journal-title":"Cell Rep"},{"issue":"4","key":"803_CR238","doi-asserted-by":"publisher","first-page":"2678","DOI":"10.1074\/jbc.M111.274142","volume":"287","author":"RB Chan","year":"2012","unstructured":"Chan RB, Oliveira TG, Cortes EP, Honig LS, Duff KE, Small SA, et al. Comparative lipidomic analysis of mouse and human brain with Alzheimer disease. J Biol Chem. 2012;287(4):2678\u201388.","journal-title":"J Biol Chem"},{"key":"803_CR239","doi-asserted-by":"publisher","first-page":"2250","DOI":"10.1038\/ncomms3250","volume":"4","author":"E Morel","year":"2013","unstructured":"Morel E, Chamoun Z, Lasiecka ZM, Chan RB, Williamson RL, Vetanovetz C, et al. Phosphatidylinositol-3-phosphate regulates sorting and processing of amyloid precursor protein through the endosomal system. Nat Commun. 2013;4:2250.","journal-title":"Nat Commun"},{"key":"803_CR240","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1177\/095952876705000105","volume":"50","author":"WH Dickinson","year":"1867","unstructured":"Dickinson WH. On the nature of the Waxy, Lardaceous, or amyloid Deposit. Med Chir Trans. 1867;50:39\u201356. 3.","journal-title":"Med Chir Trans"},{"issue":"18","key":"803_CR241","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.1073\/pnas.0407035102","volume":"102","author":"GP Gellermann","year":"2005","unstructured":"Gellermann GP, Appel TR, Tannert A, Radestock A, Hortschansky P, Schroeckh V, et al. Raft lipids as common components of human extracellular amyloid fibrils. Proc Natl Acad Sci U S A. 2005;102(18):6297\u2013302.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"803_CR242","first-page":"1","volume":"74","author":"A Rimon","year":"1976","unstructured":"Rimon A. The chemical and immunochemical identity of amyloid. Curr Top Microbiol Immunol. 1976;74:1\u201320.","journal-title":"Curr Top Microbiol Immunol"},{"issue":"8","key":"803_CR243","doi-asserted-by":"publisher","first-page":"102108","DOI":"10.1016\/j.jbc.2022.102108","volume":"298","author":"JM Sanderson","year":"2022","unstructured":"Sanderson JM. The association of lipids with amyloid fibrils. J Biol Chem. 2022;298(8):102108.","journal-title":"J Biol Chem"},{"issue":"3","key":"803_CR244","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","volume":"120","author":"GG Glenner","year":"1984","unstructured":"Glenner GG, Wong CW. Alzheimer\u2019s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984;120(3):885\u201390.","journal-title":"Biochem Biophys Res Commun"},{"issue":"4","key":"803_CR245","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/0022-2836(92)90106-T","volume":"225","author":"CJ Barrow","year":"1992","unstructured":"Barrow CJ, Yasuda A, Kenny PT, Zagorski MG. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer\u2019s disease. Analysis of circular dichroism spectra. J Mol Biol. 1992;225(4):1075\u201393.","journal-title":"J Mol Biol"},{"key":"803_CR246","doi-asserted-by":"crossref","unstructured":"Ross CA, Poirier MA. Protein aggregation and neurodegenerative disease. Nat Med 2004;10 Suppl:S10-7.","DOI":"10.1038\/nm1066"},{"key":"803_CR247","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3389\/fnmol.2017.00063","volume":"10","author":"MO Grimm","year":"2017","unstructured":"Grimm MO, Mett J, Grimm HS, Hartmann T. APP function and lipids: a bidirectional link. Front Mol Neurosci. 2017;10:63.","journal-title":"Front Mol Neurosci"},{"key":"803_CR248","first-page":"857","volume":"317","author":"GG Glenner","year":"1989","unstructured":"Glenner GG. Amyloid beta protein and the basis for Alzheimer\u2019s disease. Prog Clin Biol Res. 1989;317:857\u201368.","journal-title":"Prog Clin Biol Res"},{"key":"803_CR249","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3389\/fphys.2020.00598","volume":"11","author":"H Chew","year":"2020","unstructured":"Chew H, Solomon VA, Fonteh AN. Involvement of lipids in Alzheimer\u2019s Disease Pathology and potential therapies. Front Physiol. 2020;11:598.","journal-title":"Front Physiol"},{"issue":"3","key":"803_CR250","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1582-4934.2007.00054.x","volume":"11","author":"PC Reid","year":"2007","unstructured":"Reid PC, Urano Y, Kodama T, Hamakubo T. Alzheimer\u2019s disease: cholesterol, membrane rafts, isoprenoids and statins. J Cell Mol Med. 2007;11(3):383\u201392.","journal-title":"J Cell Mol Med"},{"issue":"1","key":"803_CR251","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1083\/jcb.200207113","volume":"160","author":"R Ehehalt","year":"2003","unstructured":"Ehehalt R, Keller P, Haass C, Thiele C, Simons K. Amyloidogenic processing of the Alzheimer beta-amyloid precursor protein depends on lipid rafts. J Cell Biol. 2003;160(1):113\u201323.","journal-title":"J Cell Biol"},{"issue":"Pt 3","key":"803_CR252","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1042\/BJ20040777","volume":"382","author":"R Lahdo","year":"2004","unstructured":"Lahdo R, De La Fourniere-Bessueille L. Insertion of the amyloid precursor protein into lipid monolayers: effects of cholesterol and apolipoprotein E. Biochem J. 2004;382(Pt 3):987\u201394.","journal-title":"Biochem J"},{"issue":"17","key":"803_CR253","doi-asserted-by":"publisher","first-page":"11302","DOI":"10.1074\/jbc.M801520200","volume":"283","author":"MO Grimm","year":"2008","unstructured":"Grimm MO, Grimm HS, Tomic I, Beyreuther K, Hartmann T, Bergmann C. Independent inhibition of Alzheimer disease beta- and gamma-secretase cleavage by lowered cholesterol levels. J Biol Chem. 2008;283(17):11302\u201311.","journal-title":"J Biol Chem"},{"key":"803_CR254","doi-asserted-by":"publisher","first-page":"842814","DOI":"10.3389\/fnins.2022.842814","volume":"16","author":"M Wu","year":"2022","unstructured":"Wu M, Zhai Y, Liang X, Chen W, Lin R, Ma L, et al. Connecting the dots between Hypercholesterolemia and Alzheimer\u2019s Disease: a potential mechanism based on 27-Hydroxycholesterol. Front Neurosci. 2022;16:842814.","journal-title":"Front Neurosci"},{"issue":"3","key":"803_CR255","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1091\/mbc.E20-05-0345","volume":"32","author":"VF Langness","year":"2021","unstructured":"Langness VF, van der Kant R, Das U, Wang L, Chaves RDS, Goldstein LSB. Cholesterol-lowering drugs reduce APP processing to Abeta by inducing APP dimerization. Mol Biol Cell. 2021;32(3):247\u201359.","journal-title":"Mol Biol Cell"},{"issue":"16","key":"803_CR256","doi-asserted-by":"publisher","first-page":"14028","DOI":"10.1074\/jbc.M110.182329","volume":"286","author":"MO Grimm","year":"2011","unstructured":"Grimm MO, Kuchenbecker J, Grosgen S, Burg VK, Hundsdorfer B, Rothhaar TL, et al. Docosahexaenoic acid reduces amyloid beta production via multiple pleiotropic mechanisms. J Biol Chem. 2011;286(16):14028\u201339.","journal-title":"J Biol Chem"},{"issue":"Pt 1","key":"803_CR257","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1042\/BJ20050700","volume":"391","author":"C Costantini","year":"2005","unstructured":"Costantini C, Weindruch R, Della Valle G, Puglielli L. A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging. Biochem J. 2005;391(Pt 1):59\u201367.","journal-title":"Biochem J"},{"issue":"2","key":"803_CR258","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbrc.2014.12.087","volume":"457","author":"N Takasugi","year":"2015","unstructured":"Takasugi N, Sasaki T, Shinohara M, Iwatsubo T, Tomita T. Synthetic ceramide analogues increase amyloid-beta 42 production by modulating gamma-secretase activity. Biochem Biophys Res Commun. 2015;457(2):194\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"803_CR259","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1038\/ncb1313","volume":"7","author":"MO Grimm","year":"2005","unstructured":"Grimm MO, Grimm HS, Patzold AJ, Zinser EG, Halonen R, Duering M, et al. Regulation of cholesterol and sphingomyelin metabolism by amyloid-beta and presenilin. Nat Cell Biol. 2005;7(11):1118\u201323.","journal-title":"Nat Cell Biol"},{"key":"803_CR260","doi-asserted-by":"crossref","unstructured":"Rudajev V, Novotny J. The role of lipid environment in Ganglioside GM1-Induced amyloid beta aggregation. Membr (Basel) 2020;10(9).","DOI":"10.3390\/membranes10090226"},{"issue":"24","key":"803_CR261","doi-asserted-by":"publisher","first-page":"4335","DOI":"10.1021\/acschemneuro.3c00524","volume":"14","author":"J Hu","year":"2023","unstructured":"Hu J, Linse S, Sparr E. Ganglioside Micelles affect amyloid beta aggregation by Coassembly. ACS Chem Neurosci. 2023;14(24):4335\u201343.","journal-title":"ACS Chem Neurosci"},{"issue":"32","key":"803_CR262","doi-asserted-by":"publisher","first-page":"9411","DOI":"10.1002\/anie.201603178","volume":"55","author":"M Amaro","year":"2016","unstructured":"Amaro M, Sachl R, Aydogan G, Mikhalyov II, Vacha R, Hof M. GM1 Ganglioside inhibits beta-amyloid Oligomerization Induced by Sphingomyelin. Angew Chem Int Ed Engl. 2016;55(32):9411\u20135.","journal-title":"Angew Chem Int Ed Engl"},{"key":"803_CR263","doi-asserted-by":"publisher","first-page":"32570","DOI":"10.3402\/jev.v5.32570","volume":"5","author":"RA Haraszti","year":"2016","unstructured":"Haraszti RA, Didiot MC, Sapp E, Leszyk J, Shaffer SA, Rockwell HE, et al. High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources. J Extracell Vesicles. 2016;5:32570.","journal-title":"J Extracell Vesicles"},{"issue":"7","key":"803_CR264","doi-asserted-by":"publisher","first-page":"e12089","DOI":"10.1002\/jev2.12089","volume":"10","author":"H Su","year":"2021","unstructured":"Su H, Rustam YH, Masters CL, Makalic E, McLean CA, Hill AF, et al. Characterization of brain-derived extracellular vesicle lipids in Alzheimer\u2019s disease. J Extracell Vesicles. 2021;10(7):e12089.","journal-title":"J Extracell Vesicles"},{"issue":"30","key":"803_CR265","doi-asserted-by":"publisher","first-page":"11172","DOI":"10.1073\/pnas.0603838103","volume":"103","author":"L Rajendran","year":"2006","unstructured":"Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, et al. Alzheimer\u2019s disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A. 2006;103(30):11172\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"803_CR266","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3233\/JAD-2010-1206","volume":"19","author":"A Bulloj","year":"2010","unstructured":"Bulloj A, Leal MC, Xu H, Castano EM, Morelli L. Insulin-degrading enzyme sorting in exosomes: a secretory pathway for a key brain amyloid-beta degrading protease. J Alzheimers Dis. 2010;19(1):79\u201395.","journal-title":"J Alzheimers Dis"},{"issue":"48","key":"803_CR267","doi-asserted-by":"publisher","first-page":"37405","DOI":"10.1074\/jbc.M110.149468","volume":"285","author":"IY Tamboli","year":"2010","unstructured":"Tamboli IY, Barth E, Christian L, Siepmann M, Kumar S, Singh S, et al. Statins promote the degradation of extracellular amyloid beta-peptide by microglia via stimulation of exosome-associated insulin-degrading enzyme (IDE) secretion. J Biol Chem. 2010;285(48):37405\u201314.","journal-title":"J Biol Chem"},{"issue":"6","key":"803_CR268","doi-asserted-by":"publisher","first-page":"168464","DOI":"10.1016\/j.jmb.2024.168464","volume":"436","author":"A Khursheed","year":"2024","unstructured":"Khursheed A, Viles JH. Impact of membrane phospholipids and exosomes on the kinetics of amyloid-beta Fibril Assembly. J Mol Biol. 2024;436(6):168464.","journal-title":"J Mol Biol"},{"issue":"3","key":"803_CR269","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/j.1471-4159.2008.05481.x","volume":"106","author":"Y Zeng","year":"2008","unstructured":"Zeng Y, Han X. Sulfatides facilitate apolipoprotein E-mediated amyloid-beta peptide clearance through an endocytotic pathway. J Neurochem. 2008;106(3):1275\u201386.","journal-title":"J Neurochem"},{"issue":"25","key":"803_CR270","doi-asserted-by":"publisher","first-page":"e202215785","DOI":"10.1002\/anie.202215785","volume":"62","author":"JH Viles","year":"2023","unstructured":"Viles JH. Imaging amyloid-beta membrane interactions: Ion-Channel pores and lipid-bilayer permeability in Alzheimer\u2019s Disease. Angew Chem Int Ed Engl. 2023;62(25):e202215785.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"1","key":"803_CR271","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","volume":"8","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Chen H, Li R, Sterling K, Song W. Amyloid beta-based therapy for Alzheimer\u2019s disease: challenges, successes and future. Signal Transduct Target Ther. 2023;8(1):248.","journal-title":"Signal Transduct Target Ther"},{"issue":"5594","key":"803_CR272","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe DJ. Alzheimer\u2019s disease is a synaptic failure. Science. 2002;298(5594):789\u201391.","journal-title":"Science"},{"issue":"11","key":"803_CR273","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1016\/S0891-5849(02)00794-3","volume":"32","author":"DA Butterfield","year":"2002","unstructured":"Butterfield DA, Lauderback CM. Lipid peroxidation and protein oxidation in Alzheimer\u2019s disease brain: potential causes and consequences involving amyloid beta-peptide-associated free radical oxidative stress. Free Radic Biol Med. 2002;32(11):1050\u201360.","journal-title":"Free Radic Biol Med"},{"issue":"5","key":"803_CR274","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/S0891-5849(02)00807-9","volume":"33","author":"TJ Montine","year":"2002","unstructured":"Montine TJ, Neely MD, Quinn JF, Beal MF, Markesbery WR, Roberts LJ, et al. Lipid peroxidation in aging brain and Alzheimer\u2019s disease. Free Radic Biol Med. 2002;33(5):620\u20136.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"803_CR275","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/ni.3102","volume":"16","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Golenbock DT, Latz E. Innate immunity in Alzheimer\u2019s disease. Nat Immunol. 2015;16(3):229\u201336.","journal-title":"Nat Immunol"},{"issue":"25","key":"803_CR276","doi-asserted-by":"publisher","first-page":"6023","DOI":"10.1021\/bi00320a019","volume":"23","author":"EJ Aamodt","year":"1984","unstructured":"Aamodt EJ, Williams RC Jr. Microtubule-associated proteins connect microtubules and neurofilaments in vitro. Biochemistry. 1984;23(25):6023\u201331.","journal-title":"Biochemistry"},{"issue":"2","key":"803_CR277","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1365-2990.1987.tb00174.x","volume":"13","author":"EG Gray","year":"1987","unstructured":"Gray EG, Paula-Barbosa M, Roher A. Alzheimer\u2019s disease: paired helical filaments and cytomembranes. Neuropathol Appl Neurobiol. 1987;13(2):91\u2013110.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"2","key":"803_CR278","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1046\/j.1471-4159.1996.67020723.x","volume":"67","author":"WJ Goux","year":"1996","unstructured":"Goux WJ, Rodriguez S, Sparkman DR. Characterization of the glycolipid associated with Alzheimer paired helical filaments. J Neurochem. 1996;67(2):723\u201333.","journal-title":"J Neurochem"},{"issue":"9","key":"803_CR279","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1515\/BC.2006.157","volume":"387","author":"GP Gellermann","year":"2006","unstructured":"Gellermann GP, Appel TR, Davies P, Diekmann S. Paired helical filaments contain small amounts of cholesterol, phosphatidylcholine and sphingolipids. Biol Chem. 2006;387(9):1267\u201374.","journal-title":"Biol Chem"},{"key":"803_CR280","doi-asserted-by":"crossref","unstructured":"Cheng KH, Graf A, Lewis A, Pham T, Acharya A. Exploring membrane binding targets of Disordered Human tau aggregates on lipid rafts using Multiscale Molecular Dynamics simulations. Membr (Basel) 2022;12(11).","DOI":"10.3390\/membranes12111098"},{"issue":"7","key":"803_CR281","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/nan.12288","volume":"42","author":"T Nishikawa","year":"2016","unstructured":"Nishikawa T, Takahashi T, Nakamori M, Hosomi N, Maruyama H, Miyazaki Y, et al. The identification of raft-derived tau-associated vesicles that are incorporated into immature tangles and paired helical filaments. Neuropathol Appl Neurobiol. 2016;42(7):639\u201353.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"15","key":"803_CR282","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1523\/JNEUROSCI.5543-03.2004","volume":"24","author":"T Kawarabayashi","year":"2004","unstructured":"Kawarabayashi T, Shoji M, Younkin LH, Wen-Lang L, Dickson DW, Murakami T, et al. Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer\u2019s disease. J Neurosci. 2004;24(15):3801\u20139.","journal-title":"J Neurosci"},{"issue":"11","key":"803_CR283","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.1016\/j.bpj.2010.03.013","volume":"98","author":"S Elbaum-Garfinkle","year":"2010","unstructured":"Elbaum-Garfinkle S, Ramlall T, Rhoades E. The role of the lipid bilayer in tau aggregation. Biophys J. 2010;98(11):2722\u201330.","journal-title":"Biophys J"},{"key":"803_CR284","doi-asserted-by":"publisher","first-page":"725241","DOI":"10.3389\/fcell.2021.725241","volume":"9","author":"CA Sallaberry","year":"2021","unstructured":"Sallaberry CA, Voss BJ, Majewski J, Biernat J, Mandelkow E, Chi EY, et al. Tau and membranes: interactions that promote folding and condensation. Front Cell Dev Biol. 2021;9:725241.","journal-title":"Front Cell Dev Biol"},{"issue":"42","key":"803_CR285","doi-asserted-by":"publisher","first-page":"15304","DOI":"10.1074\/jbc.RA119.010003","volume":"294","author":"AM Fanni","year":"2019","unstructured":"Fanni AM, Vander Zanden CM, Majewska PV, Majewski J, Chi EY. Membrane-mediated fibrillation and toxicity of the tau hexapeptide PHF6. J Biol Chem. 2019;294(42):15304\u201317.","journal-title":"J Biol Chem"},{"issue":"12","key":"803_CR286","doi-asserted-by":"publisher","first-page":"4604","DOI":"10.1039\/D1NR05960B","volume":"14","author":"QQ Yao","year":"2022","unstructured":"Yao QQ, Wen J, Perrett S, Wu S. Distinct lipid membrane-mediated pathways of tau assembly revealed by single-molecule analysis. Nanoscale. 2022;14(12):4604\u201313.","journal-title":"Nanoscale"},{"issue":"1","key":"803_CR287","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s42003-023-04847-6","volume":"6","author":"N El Mammeri","year":"2023","unstructured":"El Mammeri N, Gampp O, Duan P, Hong M. Membrane-induced tau amyloid fibrils. Commun Biol. 2023;6(1):467.","journal-title":"Commun Biol"},{"issue":"9","key":"803_CR288","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1016\/j.bbamem.2012.03.019","volume":"1818","author":"G Kunze","year":"2012","unstructured":"Kunze G, Barre P, Scheidt HA, Thomas L, Eliezer D, Huster D. Binding of the three-repeat domain of tau to phospholipid membranes induces an aggregated-like state of the protein. Biochim Biophys Acta. 2012;1818(9):2302\u201313.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"803_CR289","doi-asserted-by":"publisher","first-page":"13324","DOI":"10.1038\/s41598-020-70208-6","volume":"10","author":"J Majewski","year":"2020","unstructured":"Majewski J, Jones EM, Vander Zanden CM, Biernat J, Mandelkow E, Chi EY. Lipid membrane templated misfolding and self-assembly of intrinsically disordered tau protein. Sci Rep. 2020;10(1):13324.","journal-title":"Sci Rep"},{"issue":"1","key":"803_CR290","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/0014-5793(95)00590-6","volume":"368","author":"M Mercken","year":"1995","unstructured":"Mercken M, Grynspan F, Nixon RA. Differential sensitivity to proteolysis by brain calpain of adult human tau, fetal human tau and PHF-tau. FEBS Lett. 1995;368(1):10\u20134.","journal-title":"FEBS Lett"},{"issue":"2","key":"803_CR291","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0022-2836(77)90214-5","volume":"116","author":"DW Cleveland","year":"1977","unstructured":"Cleveland DW, Hwo SY, Kirschner MW. Physical and chemical properties of purified tau factor and the role of tau in microtubule assembly. J Mol Biol. 1977;116(2):227\u201347.","journal-title":"J Mol Biol"},{"issue":"1","key":"803_CR292","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1073\/pnas.94.1.298","volume":"94","author":"AD Alonso","year":"1997","unstructured":"Alonso AD, Grundke-Iqbal I, Barra HS, Iqbal K. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc Natl Acad Sci U S A. 1997;94(1):298\u2013303.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"803_CR293","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1002\/alz.14078","volume":"20","author":"DM Soni","year":"2024","unstructured":"Soni DM, Lin PB, Lee-Gosselin A, Lloyd CD, Mason E, Ingraham CM, et al. Inpp5d haplodeficiency alleviates tau pathology in the PS19 mouse model of Tauopathy. Alzheimers Dement. 2024;20(7):4985\u201398.","journal-title":"Alzheimers Dement"},{"issue":"8","key":"803_CR294","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1007\/s12035-023-03886-8","volume":"61","author":"VM Garcia-Cruz","year":"2024","unstructured":"Garcia-Cruz VM, Arias C. Palmitic acid induces posttranslational modifications of tau protein in Alzheimer\u2019s Disease-related epitopes and increases intraneuronal tau levels. Mol Neurobiol. 2024;61(8):5129\u201341.","journal-title":"Mol Neurobiol"},{"issue":"2","key":"803_CR295","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1046\/j.1471-4159.2001.00063.x","volume":"76","author":"QW Fan","year":"2001","unstructured":"Fan QW, Yu W, Senda T, Yanagisawa K, Michikawa M. Cholesterol-dependent modulation of tau phosphorylation in cultured neurons. J Neurochem. 2001;76(2):391\u2013400.","journal-title":"J Neurochem"},{"issue":"1","key":"803_CR296","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y. Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflammation. 2023;20(1):165.","journal-title":"J Neuroinflammation"},{"issue":"SupplSuppl","key":"803_CR297","doi-asserted-by":"publisher","first-page":"S266","DOI":"10.1194\/jlr.R800064-JLR200","volume":"50","author":"AC Newton","year":"2009","unstructured":"Newton AC. Lipid activation of protein kinases. J Lipid Res. 2009;50(SupplSuppl):S266\u201371.","journal-title":"J Lipid Res"},{"issue":"19","key":"803_CR298","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1074\/jbc.273.19.11514","volume":"273","author":"NR Murray","year":"1998","unstructured":"Murray NR, Fields AP. Phosphatidylglycerol is a physiologic activator of nuclear protein kinase C. J Biol Chem. 1998;273(19):11514\u201320.","journal-title":"J Biol Chem"},{"issue":"1","key":"803_CR299","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12974-024-03060-4","volume":"21","author":"D Olesova","year":"2024","unstructured":"Olesova D, Dobesova D, Majerova P, Brumarova R, Kvasnicka A, Kouril S, et al. Changes in lipid metabolism track with the progression of neurofibrillary pathology in tauopathies. J Neuroinflammation. 2024;21(1):78.","journal-title":"J Neuroinflammation"},{"key":"803_CR300","doi-asserted-by":"publisher","first-page":"4754195","DOI":"10.1155\/2020\/4754195","volume":"2020","author":"W Yang","year":"2020","unstructured":"Yang W, Liu Y, Xu QQ, Xian YF, Lin ZX. Sulforaphene ameliorates Neuroinflammation and Hyperphosphorylated tau protein via regulating the PI3K\/Akt\/GSK-3beta pathway in experimental models of Alzheimer\u2019s Disease. Oxid Med Cell Longev. 2020;2020:4754195.","journal-title":"Oxid Med Cell Longev"},{"issue":"9","key":"803_CR301","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1007\/s12035-022-02945-w","volume":"59","author":"M Mai","year":"2022","unstructured":"Mai M, Guo X, Huang Y, Zhang W, Xu Y, Zhang Y, et al. DHCR24 Knockdown induces tau hyperphosphorylation at Thr181, Ser199, Ser262, and Ser396 sites via activation of the lipid raft-dependent Ras\/MEK\/ERK Signaling pathway in C8D1A astrocytes. Mol Neurobiol. 2022;59(9):5856\u201373.","journal-title":"Mol Neurobiol"},{"key":"803_CR302","doi-asserted-by":"publisher","first-page":"109016","DOI":"10.1016\/j.jnutbio.2022.109016","volume":"106","author":"T Wang","year":"2022","unstructured":"Wang T, Zhang X, Wang Y, Liu W, Wang L, Hao L, et al. High cholesterol and 27-hydroxycholesterol contribute to phosphorylation of tau protein by impairing autophagy causing learning and memory impairment in C57BL\/6J mice. J Nutr Biochem. 2022;106:109016.","journal-title":"J Nutr Biochem"},{"key":"803_CR303","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.nbd.2014.05.033","volume":"72","author":"M Malnar","year":"2014","unstructured":"Malnar M, Hecimovic S, Mattsson N, Zetterberg H. Bidirectional links between Alzheimer\u2019s disease and Niemann-pick type C disease. Neurobiol Dis. 2014;72:37\u201347.","journal-title":"Neurobiol Dis"},{"key":"803_CR304","doi-asserted-by":"publisher","first-page":"667","DOI":"10.3389\/fnins.2017.00667","volume":"11","author":"K Yamada","year":"2017","unstructured":"Yamada K. Extracellular tau and its potential role in the propagation of Tau Pathology. Front Neurosci. 2017;11:667.","journal-title":"Front Neurosci"},{"key":"803_CR305","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3389\/fnmol.2019.00107","volume":"12","author":"E Vasili","year":"2019","unstructured":"Vasili E, Dominguez-Meijide A, Outeiro TF. Spreading of alpha-synuclein and tau: a systematic comparison of the mechanisms involved. Front Mol Neurosci. 2019;12:107.","journal-title":"Front Mol Neurosci"},{"issue":"6","key":"803_CR306","doi-asserted-by":"publisher","first-page":"e100760","DOI":"10.1371\/journal.pone.0100760","volume":"9","author":"S Dujardin","year":"2014","unstructured":"Dujardin S, Begard S, Caillierez R, Lachaud C, Delattre L, Carrier S, et al. Ectosomes: a new mechanism for non-exosomal secretion of tau protein. PLoS ONE. 2014;9(6):e100760.","journal-title":"PLoS ONE"},{"key":"803_CR307","doi-asserted-by":"crossref","unstructured":"Lee J, Ye Y. The roles of endo-lysosomes in unconventional protein secretion. Cells 2018;7(11).","DOI":"10.3390\/cells7110198"},{"issue":"1","key":"803_CR308","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1038\/s41467-017-01575-4","volume":"8","author":"N Ait-Bouziad","year":"2017","unstructured":"Ait-Bouziad N, Lv G, Mahul-Mellier AL, Xiao S, Zorludemir G, Eliezer D, et al. Discovery and characterization of stable and toxic Tau\/phospholipid oligomeric complexes. Nat Commun. 2017;8(1):1678.","journal-title":"Nat Commun"},{"issue":"7","key":"803_CR309","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1016\/j.celrep.2018.04.056","volume":"23","author":"T Katsinelos","year":"2018","unstructured":"Katsinelos T, Zeitler M, Dimou E, Karakatsani A, Muller HM, Nachman E, et al. Unconventional secretion mediates the trans-cellular spreading of tau. Cell Rep. 2018;23(7):2039\u201355.","journal-title":"Cell Rep"},{"issue":"8","key":"803_CR310","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1016\/j.celrep.2018.10.078","volume":"25","author":"M Merezhko","year":"2018","unstructured":"Merezhko M, Brunello CA, Yan X, Vihinen H, Jokitalo E, Uronen RL, et al. Secretion of tau via an unconventional non-vesicular mechanism. Cell Rep. 2018;25(8):2027\u201335. e4.","journal-title":"Cell Rep"},{"issue":"5","key":"803_CR311","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/S0531-5565(98)00013-8","volume":"33","author":"EG McGeer","year":"1998","unstructured":"McGeer EG, McGeer PL. The importance of inflammatory mechanisms in Alzheimer disease. Exp Gerontol. 1998;33(5):371\u20138.","journal-title":"Exp Gerontol"},{"issue":"3","key":"803_CR312","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","volume":"35","author":"T Wyss-Coray","year":"2002","unstructured":"Wyss-Coray T, Mucke L. Inflammation in neurodegenerative disease\u2013a double-edged sword. Neuron. 2002;35(3):419\u201332.","journal-title":"Neuron"},{"issue":"7203","key":"803_CR313","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R. Origin and physiological roles of inflammation. Nature. 2008;454(7203):428\u201335.","journal-title":"Nature"},{"issue":"11","key":"803_CR314","doi-asserted-by":"publisher","first-page":"6460","DOI":"10.1073\/pnas.95.11.6460","volume":"95","author":"M Simons","year":"1998","unstructured":"Simons M, Keller P, De Strooper B, Beyreuther K, Dotti CG, Simons K. Cholesterol depletion inhibits the generation of beta-amyloid in hippocampal neurons. Proc Natl Acad Sci U S A. 1998;95(11):6460\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"803_CR315","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/S1074-7613(03)00092-X","volume":"18","author":"DF Legler","year":"2003","unstructured":"Legler DF, Micheau O, Doucey MA, Tschopp J, Bron C. Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. Immunity. 2003;18(5):655\u201364.","journal-title":"Immunity"},{"key":"803_CR316","doi-asserted-by":"publisher","first-page":"108486","DOI":"10.1016\/j.pharmthera.2023.108486","volume":"249","author":"SB Hansen","year":"2023","unstructured":"Hansen SB, Wang H. The shared role of cholesterol in neuronal and peripheral inflammation. Pharmacol Ther. 2023;249:108486.","journal-title":"Pharmacol Ther"},{"issue":"4","key":"803_CR317","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3233\/JAD-2011-101512","volume":"24","author":"L Mateos","year":"2011","unstructured":"Mateos L, Ismail MA, Gil-Bea FJ, Leoni V, Winblad B, Bjorkhem I, et al. Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer\u2019s disease. J Alzheimers Dis. 2011;24(4):669\u201379.","journal-title":"J Alzheimers Dis"},{"key":"803_CR318","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.redox.2016.09.001","volume":"10","author":"G Testa","year":"2016","unstructured":"Testa G, Staurenghi E, Zerbinati C, Gargiulo S, Iuliano L, Giaccone G, et al. Changes in brain oxysterols at different stages of Alzheimer\u2019s disease: their involvement in neuroinflammation. Redox Biol. 2016;10:24\u201333.","journal-title":"Redox Biol"},{"issue":"5","key":"803_CR319","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1002\/cne.21605","volume":"507","author":"DM Ramirez","year":"2008","unstructured":"Ramirez DM, Andersson S, Russell DW. Neuronal expression and subcellular localization of cholesterol 24-hydroxylase in the mouse brain. J Comp Neurol. 2008;507(5):1676\u201393.","journal-title":"J Comp Neurol"},{"key":"803_CR320","doi-asserted-by":"crossref","unstructured":"Testa G, Giannelli S, Sottero B, Staurenghi E, Giaccone G, Caroppo P et al. 24-Hydroxycholesterol Induces Tau Proteasome-Dependent Degradation via the SIRT1\/PGC1alpha\/Nrf2 Pathway: A Potential Mechanism to Counteract Alzheimer\u2019s Disease. Antioxid (Basel) 2023;12(3).","DOI":"10.3390\/antiox12030631"},{"key":"803_CR321","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-030-60204-8_3","volume":"1299","author":"T Nury","year":"2020","unstructured":"Nury T, Yammine A, Menetrier F, Zarrouk A, Vejux A, Lizard G. 7-Ketocholesterol- and 7beta-Hydroxycholesterol-Induced Peroxisomal disorders in glial, microglial and neuronal cells: potential role in Neurodegeneration: 7-ketocholesterol and 7beta-hydroxycholesterol-Induced Peroxisomal disorders and Neurodegeneration. Adv Exp Med Biol. 2020;1299:31\u201341.","journal-title":"Adv Exp Med Biol"},{"key":"803_CR322","doi-asserted-by":"crossref","unstructured":"Toral-Rios D, Long JM, Ulrich JD, Yu J, Strickland MR, Han X et al. Cholesterol 25-hydroxylase mediates neuroinflammation and neurodegeneration in a mouse model of tauopathy. J Exp Med 2024;221(4).","DOI":"10.1084\/jem.20232000"},{"issue":"11","key":"803_CR323","doi-asserted-by":"publisher","first-page":"8077","DOI":"10.4049\/jimmunol.181.11.8077","volume":"181","author":"SB Jeon","year":"2008","unstructured":"Jeon SB, Yoon HJ, Park SH, Kim IH, Park EJ. Sulfatide, a major lipid component of myelin sheath, activates inflammatory responses as an endogenous stimulator in brain-resident immune cells. J Immunol. 2008;181(11):8077\u201387.","journal-title":"J Immunol"},{"issue":"7503","key":"803_CR324","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nature13479","volume":"510","author":"CN Serhan","year":"2014","unstructured":"Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature. 2014;510(7503):92\u2013101.","journal-title":"Nature"},{"issue":"5","key":"803_CR325","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nri2294","volume":"8","author":"CN Serhan","year":"2008","unstructured":"Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008;8(5):349\u201361.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"803_CR326","doi-asserted-by":"publisher","first-page":"697","DOI":"10.3233\/JAD-130131","volume":"35","author":"E Hjorth","year":"2013","unstructured":"Hjorth E, Zhu M, Toro VC, Vedin I, Palmblad J, Cederholm T, et al. Omega-3 fatty acids enhance phagocytosis of Alzheimer\u2019s disease-related amyloid-beta42 by human microglia and decrease inflammatory markers. J Alzheimers Dis. 2013;35(4):697\u2013713.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"803_CR327","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.neurobiolaging.2006.04.006","volume":"28","author":"AM Lynch","year":"2007","unstructured":"Lynch AM, Loane DJ, Minogue AM, Clarke RM, Kilroy D, Nally RE, et al. Eicosapentaenoic acid confers neuroprotection in the amyloid-beta challenged aged hippocampus. Neurobiol Aging. 2007;28(6):845\u201355.","journal-title":"Neurobiol Aging"},{"issue":"5","key":"803_CR328","doi-asserted-by":"publisher","first-page":"e36861","DOI":"10.1371\/journal.pone.0036861","volume":"7","author":"VF Labrousse","year":"2012","unstructured":"Labrousse VF, Nadjar A, Joffre C, Costes L, Aubert A, Gregoire S, et al. Short-term long chain omega3 diet protects from neuroinflammatory processes and memory impairment in aged mice. PLoS ONE. 2012;7(5):e36861.","journal-title":"PLoS ONE"},{"issue":"1","key":"803_CR329","doi-asserted-by":"publisher","first-page":"e15816","DOI":"10.1371\/journal.pone.0015816","volume":"6","author":"Y Zhao","year":"2011","unstructured":"Zhao Y, Calon F, Julien C, Winkler JW, Petasis NA, Lukiw WJ, et al. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPARgamma-mediated mechanisms in Alzheimer\u2019s disease models. PLoS ONE. 2011;6(1):e15816.","journal-title":"PLoS ONE"},{"key":"803_CR330","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neuroscience.2018.11.030","volume":"397","author":"M Youssef","year":"2019","unstructured":"Youssef M, Ibrahim A, Akashi K, Hossain MS. PUFA-Plasmalogens attenuate the LPS-Induced nitric oxide production by inhibiting the NF-kB, p38 MAPK and JNK pathways in Microglial cells. Neuroscience. 2019;397:18\u201330.","journal-title":"Neuroscience"},{"issue":"4","key":"803_CR331","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.bbrc.2018.01.078","volume":"496","author":"MS Hossain","year":"2018","unstructured":"Hossain MS, Tajima A, Kotoura S, Katafuchi T. Oral ingestion of plasmalogens can attenuate the LPS-induced memory loss and microglial activation. Biochem Biophys Res Commun. 2018;496(4):1033\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"803_CR332","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1742-2094-9-197","volume":"9","author":"M Ifuku","year":"2012","unstructured":"Ifuku M, Katafuchi T, Mawatari S, Noda M, Miake K, Sugiyama M, et al. Anti-inflammatory\/anti-amyloidogenic effects of plasmalogens in lipopolysaccharide-induced neuroinflammation in adult mice. J Neuroinflammation. 2012;9:197.","journal-title":"J Neuroinflammation"},{"issue":"15","key":"803_CR333","doi-asserted-by":"publisher","first-page":"4074","DOI":"10.1523\/JNEUROSCI.3941-15.2017","volume":"37","author":"MS Hossain","year":"2017","unstructured":"Hossain MS, Abe Y, Ali F, Youssef M, Honsho M, Fujiki Y, et al. Reduction of Ether-Type glycerophospholipids, Plasmalogens, by NF-kappaB Signal Leading to Microglial activation. J Neurosci. 2017;37(15):4074\u201392.","journal-title":"J Neurosci"},{"key":"803_CR334","doi-asserted-by":"publisher","first-page":"117957352090739","DOI":"10.1177\/1179573520907397","volume":"12","author":"KG Yiannopoulou","year":"2020","unstructured":"Yiannopoulou KG, Papageorgiou SG. Current and future treatments in Alzheimer Disease: an update. J Cent Nerv Syst Dis. 2020;12:1179573520907397.","journal-title":"J Cent Nerv Syst Dis"},{"issue":"7","key":"803_CR335","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1093\/brain\/awy132","volume":"141","author":"H Hampel","year":"2018","unstructured":"Hampel H, Mesulam MM, Cuello AC, Farlow MR, Giacobini E, Grossberg GT, et al. The cholinergic system in the pathophysiology and treatment of Alzheimer\u2019s disease. Brain. 2018;141(7):1917\u201333.","journal-title":"Brain"},{"issue":"4","key":"803_CR336","doi-asserted-by":"publisher","first-page":"e0123289","DOI":"10.1371\/journal.pone.0123289","volume":"10","author":"S Matsunaga","year":"2015","unstructured":"Matsunaga S, Kishi T, Iwata N. Memantine monotherapy for Alzheimer\u2019s disease: a systematic review and meta-analysis. PLoS ONE. 2015;10(4):e0123289.","journal-title":"PLoS ONE"},{"issue":"3","key":"803_CR337","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/S0896-6273(01)00317-8","volume":"30","author":"RA Cherny","year":"2001","unstructured":"Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, et al. Treatment with a copper-zinc chelator markedly and rapidly inhibits beta-amyloid accumulation in Alzheimer\u2019s disease transgenic mice. Neuron. 2001;30(3):665\u201376.","journal-title":"Neuron"},{"issue":"1","key":"803_CR338","first-page":"CD004816","volume":"2013","author":"F Taylor","year":"2013","unstructured":"Taylor F, Huffman MD, Macedo AF, Moore TH, Burke M, Davey Smith G, et al. Statins for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2013;2013(1):CD004816.","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"803_CR339","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.1073\/pnas.77.7.3957","volume":"77","author":"AW Alberts","year":"1980","unstructured":"Alberts AW, Chen J, Kuron G, Hunt V, Huff J, Hoffman C, et al. Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci U S A. 1980;77(7):3957\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"803_CR340","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1073\/pnas.081620098","volume":"98","author":"K Fassbender","year":"2001","unstructured":"Fassbender K, Simons M, Bergmann C, Stroick M, Lutjohann D, Keller P, et al. Simvastatin strongly reduces levels of Alzheimer\u2019s disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. Proc Natl Acad Sci U S A. 2001;98(10):5856\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"29","key":"803_CR341","doi-asserted-by":"publisher","first-page":"22091","DOI":"10.1074\/jbc.M110.102277","volume":"285","author":"M Shinohara","year":"2010","unstructured":"Shinohara M, Sato N, Kurinami H, Takeuchi D, Takeda S, Shimamura M, et al. Reduction of brain beta-amyloid (abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and abeta clearance. J Biol Chem. 2010;285(29):22091\u2013102.","journal-title":"J Biol Chem"},{"issue":"12","key":"803_CR342","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1194\/jlr.R075630","volume":"58","author":"TY Chang","year":"2017","unstructured":"Chang TY, Yamauchi Y, Hasan MT, Chang C. Cellular cholesterol homeostasis and Alzheimer\u2019s disease. J Lipid Res. 2017;58(12):2239\u201354.","journal-title":"J Lipid Res"},{"issue":"2","key":"803_CR343","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11886-014-0559-3","volume":"17","author":"S Chatterjee","year":"2015","unstructured":"Chatterjee S, Krishnamoorthy P, Ranjan P, Roy A, Chakraborty A, Sabharwal MS, et al. Statins and cognitive function: an updated review. Curr Cardiol Rep. 2015;17(2):4.","journal-title":"Curr Cardiol Rep"},{"issue":"1","key":"803_CR344","first-page":"CD003160","volume":"2016","author":"B McGuinness","year":"2016","unstructured":"McGuinness B, Craig D, Bullock R, Passmore P. Statins for the prevention of dementia. Cochrane Database Syst Rev. 2016;2016(1):CD003160.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"803_CR345","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/01.mol.0000169351.28019.04","volume":"16","author":"M Van Eck","year":"2005","unstructured":"Van Eck M, Pennings M, Hoekstra M, Out R, Van Berkel TJ. Scavenger receptor BI and ATP-binding cassette transporter A1 in reverse cholesterol transport and atherosclerosis. Curr Opin Lipidol. 2005;16(3):307\u201315.","journal-title":"Curr Opin Lipidol"},{"issue":"12","key":"803_CR346","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1038\/s41588-022-01208-7","volume":"54","author":"H Holstege","year":"2022","unstructured":"Holstege H, Hulsman M, Charbonnier C, Grenier-Boley B, Quenez O, Grozeva D, et al. Exome sequencing identifies rare damaging variants in ATP8B4 and ABCA1 as risk factors for Alzheimer\u2019s disease. Nat Genet. 2022;54(12):1786\u201394.","journal-title":"Nat Genet"},{"issue":"52","key":"803_CR347","doi-asserted-by":"publisher","first-page":"43224","DOI":"10.1074\/jbc.M504513200","volume":"280","author":"R Koldamova","year":"2005","unstructured":"Koldamova R, Staufenbiel M, Lefterov I. Lack of ABCA1 considerably decreases brain ApoE level and increases amyloid deposition in APP23 mice. J Biol Chem. 2005;280(52):43224\u201335.","journal-title":"J Biol Chem"},{"issue":"2","key":"803_CR348","first-page":"671","volume":"118","author":"SE Wahrle","year":"2008","unstructured":"Wahrle SE, Jiang H, Parsadanian M, Kim J, Li A, Knoten A, et al. Overexpression of ABCA1 reduces amyloid deposition in the PDAPP mouse model of Alzheimer disease. J Clin Invest. 2008;118(2):671\u201382.","journal-title":"J Clin Invest"},{"issue":"3","key":"803_CR349","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1016\/j.neuron.2023.10.023","volume":"112","author":"A Litvinchuk","year":"2024","unstructured":"Litvinchuk A, Suh JH, Guo JL, Lin K, Davis SS, Bien-Ly N, et al. Amelioration of tau and ApoE4-linked glial lipid accumulation and neurodegeneration with an LXR agonist. Neuron. 2024;112(3):384\u2013e4038.","journal-title":"Neuron"},{"issue":"3","key":"803_CR350","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3233\/JAD-160467","volume":"54","author":"A Boehm-Cagan","year":"2016","unstructured":"Boehm-Cagan A, Bar R, Liraz O, Bielicki JK, Johansson JO, Michaelson DM. ABCA1 agonist reverses the ApoE4-Driven cognitive and brain pathologies. J Alzheimers Dis. 2016;54(3):1219\u201333.","journal-title":"J Alzheimers Dis"},{"key":"803_CR351","unstructured":"Safety and Pharmacokinetics of Single Ascending Doses and Multiple Ascending Doses of CS6253 in Healthy Volunteers. National Library of Medicine-ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/search?cond=Alzheimer%27s%20Disease_intr=CS6253%20. Accessed December 29 2024."},{"key":"803_CR352","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2016.04.020","volume":"44","author":"L Zhao","year":"2016","unstructured":"Zhao L, Gottesdiener AJ, Parmar M, Li M, Kaminsky SM, Chiuchiolo MJ, et al. Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer\u2019s disease mouse models. Neurobiol Aging. 2016;44:159\u201372.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"803_CR353","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/humc.2017.231","volume":"29","author":"JB Rosenberg","year":"2018","unstructured":"Rosenberg JB, Kaplitt MG, De BP, Chen A, Flagiello T, Salami C, et al. AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer\u2019s Disease. Hum Gene Ther Clin Dev. 2018;29(1):24\u201347.","journal-title":"Hum Gene Ther Clin Dev"},{"key":"803_CR354","unstructured":"Gene Therapy for APOE4 Homozygote of Alzheimer\u2019s Disease. National Library of Medicine-ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/study\/NCT03634007. Accessed December 29 2024."},{"issue":"6","key":"803_CR355","first-page":"519","volume":"21","author":"M Parikh","year":"2014","unstructured":"Parikh M, Patel K, Soni S, Gandhi T. Liver X receptor: a cardinal target for atherosclerosis and beyond. J Atheroscler Thromb. 2014;21(6):519\u201331.","journal-title":"J Atheroscler Thromb"},{"issue":"5","key":"803_CR356","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2005.06.029","volume":"122","author":"S Ogawa","year":"2005","unstructured":"Ogawa S, Lozach J, Benner C, Pascual G, Tangirala RK, Westin S, et al. Molecular determinants of crosstalk between nuclear receptors and toll-like receptors. Cell. 2005;122(5):707\u201321.","journal-title":"Cell"},{"issue":"2","key":"803_CR357","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nm820","volume":"9","author":"SB Joseph","year":"2003","unstructured":"Joseph SB, Castrillo A, Laffitte BA, Mangelsdorf DJ, Tontonoz P. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med. 2003;9(2):213\u20139.","journal-title":"Nat Med"},{"issue":"25","key":"803_CR358","doi-asserted-by":"publisher","first-page":"10601","DOI":"10.1073\/pnas.0701096104","volume":"104","author":"N Zelcer","year":"2007","unstructured":"Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan EG, Landreth GE, et al. Attenuation of neuroinflammation and Alzheimer\u2019s disease pathology by liver x receptors. Proc Natl Acad Sci U S A. 2007;104(25):10601\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"803_CR359","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/1750-1326-2-20","volume":"2","author":"I Lefterov","year":"2007","unstructured":"Lefterov I, Bookout A, Wang Z, Staufenbiel M, Mangelsdorf D, Koldamova R. Expression profiling in APP23 mouse brain: inhibition of Abeta amyloidosis and inflammation in response to LXR agonist treatment. Mol Neurodegener. 2007;2:20.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"803_CR360","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12974-024-03056-0","volume":"21","author":"R Zhang","year":"2024","unstructured":"Zhang R, Wuerch E, Yong VW, Xue M. LXR agonism for CNS diseases: promises and challenges. J Neuroinflammation. 2024;21(1):97.","journal-title":"J Neuroinflammation"},{"issue":"8","key":"803_CR361","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","volume":"14","author":"B Wang","year":"2018","unstructured":"Wang B, Tontonoz P. Liver X receptors in lipid signalling and membrane homeostasis. Nat Rev Endocrinol. 2018;14(8):452\u201363.","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"803_CR362","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cmet.2016.07.016","volume":"24","author":"TG Kirchgessner","year":"2016","unstructured":"Kirchgessner TG, Sleph P, Ostrowski J, Lupisella J, Ryan CS, Liu X, et al. Beneficial and adverse effects of an LXR agonist on human lipid and lipoprotein metabolism and circulating neutrophils. Cell Metab. 2016;24(2):223\u201333.","journal-title":"Cell Metab"},{"issue":"6","key":"803_CR363","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/0091270009335768","volume":"49","author":"A Katz","year":"2009","unstructured":"Katz A, Udata C, Ott E, Hickey L, Burczynski ME, Burghart P, et al. Safety, pharmacokinetics, and pharmacodynamics of single doses of LXR-623, a novel liver X-receptor agonist, in healthy participants. J Clin Pharmacol. 2009;49(6):643\u20139.","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"803_CR364","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.cell.2005.11.026","volume":"123","author":"M Lehrke","year":"2005","unstructured":"Lehrke M, Lazar MA. The many faces of PPARgamma. Cell. 2005;123(6):993\u20139.","journal-title":"Cell"},{"issue":"7059","key":"803_CR365","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nature03988","volume":"437","author":"G Pascual","year":"2005","unstructured":"Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, et al. A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature. 2005;437(7059):759\u201363.","journal-title":"Nature"},{"issue":"3","key":"803_CR366","doi-asserted-by":"publisher","first-page":"232","DOI":"10.2174\/1570159X16666180828100002","volume":"17","author":"MA Khan","year":"2019","unstructured":"Khan MA, Alam Q, Haque A, Ashafaq M, Khan MJ, Ashraf GM, et al. Current progress on peroxisome proliferator-activated receptor Gamma Agonist as an Emerging Therapeutic Approach for the treatment of Alzheimer\u2019s Disease: an update. Curr Neuropharmacol. 2019;17(3):232\u201346.","journal-title":"Curr Neuropharmacol"},{"issue":"30","key":"803_CR367","doi-asserted-by":"publisher","first-page":"10117","DOI":"10.1523\/JNEUROSCI.5268-11.2012","volume":"32","author":"S Mandrekar-Colucci","year":"2012","unstructured":"Mandrekar-Colucci S, Karlo JC, Landreth GE. Mechanisms underlying the rapid peroxisome proliferator-activated receptor-gamma-mediated amyloid clearance and reversal of cognitive deficits in a murine model of Alzheimer\u2019s disease. J Neurosci. 2012;32(30):10117\u201328.","journal-title":"J Neurosci"},{"issue":"48","key":"803_CR368","doi-asserted-by":"publisher","first-page":"17321","DOI":"10.1523\/JNEUROSCI.1569-12.2012","volume":"32","author":"M Yamanaka","year":"2012","unstructured":"Yamanaka M, Ishikawa T, Griep A, Axt D, Kummer MP, Heneka MT. PPARgamma\/RXRalpha-induced and CD36-mediated microglial amyloid-beta phagocytosis results in cognitive improvement in amyloid precursor protein\/presenilin 1 mice. J Neurosci. 2012;32(48):17321\u201331.","journal-title":"J Neurosci"},{"issue":"Pt 6","key":"803_CR369","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1093\/brain\/awh452","volume":"128","author":"MT Heneka","year":"2005","unstructured":"Heneka MT, Sastre M, Dumitrescu-Ozimek L, Hanke A, Dewachter I, Kuiperi C, et al. Acute treatment with the PPARgamma agonist pioglitazone and ibuprofen reduces glial inflammation and Abeta1-42 levels in APPV717I transgenic mice. Brain. 2005;128(Pt 6):1442\u201353.","journal-title":"Brain"},{"issue":"11","key":"803_CR370","first-page":"950","volume":"13","author":"GS Watson","year":"2005","unstructured":"Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry. 2005;13(11):950\u20138.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"803_CR371","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2174\/156720511796391935","volume":"8","author":"C Harrington","year":"2011","unstructured":"Harrington C, Sawchak S, Chiang C, Davies J, Donovan C, Saunders AM, et al. Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer\u2019s disease: two phase 3 studies. Curr Alzheimer Res. 2011;8(5):592\u2013606.","journal-title":"Curr Alzheimer Res"},{"issue":"7","key":"803_CR372","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S1474-4422(21)00043-0","volume":"20","author":"DK Burns","year":"2021","unstructured":"Burns DK, Alexander RC, Welsh-Bohmer KA, Culp M, Chiang C, O\u2019Neil J, et al. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer\u2019s disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Neurol. 2021;20(7):537\u201347.","journal-title":"Lancet Neurol"},{"issue":"9","key":"803_CR373","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","volume":"32","author":"T Sato","year":"2011","unstructured":"Sato T, Hanyu H, Hirao K, Kanetaka H, Sakurai H, Iwamoto T. Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease. Neurobiol Aging. 2011;32(9):1626\u201333.","journal-title":"Neurobiol Aging"},{"issue":"1","key":"803_CR374","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1532-5415.2009.02067.x","volume":"57","author":"H Hanyu","year":"2009","unstructured":"Hanyu H, Sato T, Kiuchi A, Sakurai H, Iwamoto T. Pioglitazone improved cognition in a pilot study on patients with Alzheimer\u2019s disease and mild cognitive impairment with diabetes mellitus. J Am Geriatr Soc. 2009;57(1):177\u20139.","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"803_CR375","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.3233\/JAD-190864","volume":"73","author":"S Chamberlain","year":"2020","unstructured":"Chamberlain S, Gabriel H, Strittmatter W, Didsbury J. An exploratory phase IIa study of the PPAR delta\/gamma agonist T3D-959 assessing metabolic and cognitive function in subjects with mild to moderate Alzheimer\u2019s Disease. J Alzheimers Dis. 2020;73(3):1085\u2013103.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"803_CR376","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13195-022-01097-2","volume":"14","author":"J Vina","year":"2022","unstructured":"Vina J, Escudero J, Baquero M, Cebrian M, Carbonell-Asins JA, Munoz JE, et al. Genistein effect on cognition in prodromal Alzheimer\u2019s disease patients. The GENIAL clinical trial. Alzheimers Res Ther. 2022;14(1):164.","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"803_CR377","doi-asserted-by":"publisher","first-page":"173","DOI":"10.37349\/ent.2021.00014","volume":"1","author":"TY Chang","year":"2021","unstructured":"Chang TY, Chang CCY, Harned TC, De La Torre AL, Lee J, Huynh TN, et al. Blocking cholesterol storage to treat Alzheimer\u2019s disease. Explor Neuroprotective Ther. 2021;1(3):173\u201384.","journal-title":"Explor Neuroprotective Ther"},{"issue":"18","key":"803_CR378","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.4155\/fmc.15.161","volume":"7","author":"Y Shibuya","year":"2015","unstructured":"Shibuya Y, Chang CC, Chang TY. ACAT1\/SOAT1 as a therapeutic target for Alzheimer\u2019s disease. Future Med Chem. 2015;7(18):2451\u201367.","journal-title":"Future Med Chem"},{"issue":"4","key":"803_CR379","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1007\/s13311-023-01375-3","volume":"20","author":"AC Valencia-Olvera","year":"2023","unstructured":"Valencia-Olvera AC, Balu D, Faulk N, Amiridis A, Wang Y, Pham C, et al. Inhibition of ACAT as a therapeutic target for Alzheimer\u2019s disease is Independent of ApoE4 lipidation. Neurotherapeutics. 2023;20(4):1120\u201337.","journal-title":"Neurotherapeutics"},{"issue":"7","key":"803_CR380","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1073\/pnas.0913828107","volume":"107","author":"EY Bryleva","year":"2010","unstructured":"Bryleva EY, Rogers MA, Chang CC, Buen F, Harris BT, Rousselet E, et al. ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD. Proc Natl Acad Sci U S A. 2010;107(7):3081\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"803_CR381","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1016\/j.neurobiolaging.2015.04.002","volume":"36","author":"Y Shibuya","year":"2015","unstructured":"Shibuya Y, Niu Z, Bryleva EY, Harris BT, Murphy SR, Kheirollah A, et al. Acyl-coenzyme A:cholesterol acyltransferase 1 blockage enhances autophagy in the neurons of triple transgenic Alzheimer\u2019s disease mouse and reduces human P301L-tau content at the presymptomatic stage. Neurobiol Aging. 2015;36(7):2248\u201359.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"803_CR382","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.stem.2018.12.013","volume":"24","author":"R van der Kant","year":"2019","unstructured":"van der Kant R, Langness VF, Herrera CM, Williams DA, Fong LK, Leestemaker Y, et al. Cholesterol metabolism is a Druggable Axis that independently regulates tau and amyloid-beta in iPSC-Derived Alzheimer\u2019s disease neurons. Cell Stem Cell. 2019;24(3):363\u201375. e9.","journal-title":"Cell Stem Cell"},{"issue":"21","key":"803_CR383","doi-asserted-by":"publisher","first-page":"3372","DOI":"10.1161\/01.CIR.0000147777.12010.EF","volume":"110","author":"JC Tardif","year":"2004","unstructured":"Tardif JC, Gregoire J, L\u2019Allier PL, Anderson TJ, Bertrand O, Reeves F, et al. Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation. 2004;110(21):3372\u20137.","journal-title":"Circulation"},{"issue":"3","key":"803_CR384","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1124\/jpet.103.050526","volume":"306","author":"J Sahi","year":"2003","unstructured":"Sahi J, Milad MA, Zheng X, Rose KA, Wang H, Stilgenbauer L, et al. Avasimibe induces CYP3A4 and multiple drug resistance protein 1 gene expression through activation of the pregnane X receptor. J Pharmacol Exp Ther. 2003;306(3):1027\u201334.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"803_CR385","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.atherosclerosis.2006.05.048","volume":"191","author":"M Ikenoya","year":"2007","unstructured":"Ikenoya M, Yoshinaka Y, Kobayashi H, Kawamine K, Shibuya K, Sato F, et al. A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels. Atherosclerosis. 2007;191(2):290\u20137.","journal-title":"Atherosclerosis"},{"key":"803_CR386","doi-asserted-by":"crossref","unstructured":"Vincent Leong ANF. The importance of phospholipases A2 in Alzheimer\u2019s disease mechanisms, pathology, and potential therapies. Phospholipases in Physiology and Pathology; 2023.","DOI":"10.1016\/B978-0-443-21800-2.00022-1"},{"key":"803_CR387","doi-asserted-by":"crossref","unstructured":"Hui DY, Phospholipase. A(2) enzymes in metabolic and cardiovascular diseases. Curr Opin Lipidol. 2012;23(3):235\u201340.","DOI":"10.1097\/MOL.0b013e328351b439"},{"key":"803_CR388","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0090-6980(02)00020-5","volume":"68\u201369","author":"I Kudo","year":"2002","unstructured":"Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat. 2002;68\u201369:3\u201358.","journal-title":"Prostaglandins Other Lipid Mediat"},{"issue":"6","key":"803_CR389","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1021\/acschemneuro.5b00073","volume":"6","author":"WY Ong","year":"2015","unstructured":"Ong WY, Farooqui T, Kokotos G, Farooqui AA. Synthetic and natural inhibitors of phospholipases A2: their importance for understanding and treatment of neurological disorders. ACS Chem Neurosci. 2015;6(6):814\u201331.","journal-title":"ACS Chem Neurosci"},{"key":"803_CR390","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.neuroscience.2015.05.052","volume":"300","author":"X Yang","year":"2015","unstructured":"Yang X, Sheng W, Ridgley DM, Haidekker MA, Sun GY, Lee JC. Astrocytes regulate alpha-secretase-cleaved soluble amyloid precursor protein secretion in neuronal cells: involvement of group IIA secretory phospholipase A2. Neuroscience. 2015;300:508\u201317.","journal-title":"Neuroscience"},{"issue":"11","key":"803_CR391","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/nn.2213","volume":"11","author":"RO Sanchez-Mejia","year":"2008","unstructured":"Sanchez-Mejia RO, Newman JW, Toh S, Yu GQ, Zhou Y, Halabisky B, et al. Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer\u2019s disease. Nat Neurosci. 2008;11(11):1311\u20138.","journal-title":"Nat Neurosci"},{"issue":"11","key":"803_CR392","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1089\/neu.2004.21.1683","volume":"21","author":"TJ Cunningham","year":"2004","unstructured":"Cunningham TJ, Souayah N, Jameson B, Mitchell J, Yao L. Systemic treatment of cerebral cortex lesions in rats with a new secreted phospholipase A2 inhibitor. J Neurotrauma. 2004;21(11):1683\u201391.","journal-title":"J Neurotrauma"},{"issue":"2","key":"803_CR393","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.trci.2015.06.003","volume":"1","author":"G Maher-Edwards","year":"2015","unstructured":"Maher-Edwards G, De\u2019Ath J, Barnett C, Lavrov A, Lockhart A. A 24-week study to evaluate the effect of rilapladib on cognition and cerebrospinal fluid biomarkers of Alzheimer\u2019s disease. Alzheimers Dement (N Y). 2015;1(2):131\u201340.","journal-title":"Alzheimers Dement (N Y)"},{"key":"803_CR394","unstructured":"A Positron Emission Tomography (PET). Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier, National Library of Medicine-ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/search?term=GSK2647544_viewType=Table. Accessed December 29 2024."},{"key":"803_CR395","unstructured":"GSK2647544 RD, DDI in Healthy Young and Elderly, Volunteers. National Library of Medicine-ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/search?term=GSK2647544_viewType=Table. Accessed December 29 2024."},{"key":"803_CR396","unstructured":"Safety T. Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy Volunteers, National Library of Medicine-ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/search?term=GSK2647544_viewType=Table. Accessed December 29 2024."},{"issue":"3\u20135","key":"803_CR397","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.plefa.2008.09.003","volume":"79","author":"CT Chen","year":"2008","unstructured":"Chen CT, Green JT, Orr SK, Bazinet RP. Regulation of brain polyunsaturated fatty acid uptake and turnover. Prostaglandins Leukot Essent Fat Acids. 2008;79(3\u20135):85\u201391.","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"3","key":"803_CR398","doi-asserted-by":"publisher","first-page":"151","DOI":"10.3164\/jcbn.14-10","volume":"54","author":"M Shichiri","year":"2014","unstructured":"Shichiri M. The role of lipid peroxidation in neurological disorders. J Clin Biochem Nutr. 2014;54(3):151\u201360.","journal-title":"J Clin Biochem Nutr"},{"issue":"12","key":"803_CR399","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s11745-999-0478-1","volume":"34","author":"CN Bassett","year":"1999","unstructured":"Bassett CN, Neely MD, Sidell KR, Markesbery WR, Swift LL, Montine TJ. Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer\u2019s disease and are neurotoxic when oxidized ex vivo. Lipids. 1999;34(12):1273\u201380.","journal-title":"Lipids"},{"issue":"6","key":"803_CR400","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/00075197-200211000-00006","volume":"5","author":"BP Rutten","year":"2002","unstructured":"Rutten BP, Steinbusch HW, Korr H, Schmitz C. Antioxidants and Alzheimer\u2019s disease: from bench to bedside (and back again). Curr Opin Clin Nutr Metab Care. 2002;5(6):645\u201351.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"4","key":"803_CR401","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3233\/JAD-2012-121630","volume":"33","author":"M Cankurtaran","year":"2013","unstructured":"Cankurtaran M, Yesil Y, Kuyumcu ME, Ozturk ZA, Yavuz BB, Halil M, et al. Altered levels of homocysteine and serum natural antioxidants links oxidative damage to Alzheimer\u2019s disease. J Alzheimers Dis. 2013;33(4):1051\u20138.","journal-title":"J Alzheimers Dis"},{"issue":"1\u20132","key":"803_CR402","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.mam.2004.02.013","volume":"25","author":"J Vina","year":"2004","unstructured":"Vina J, Lloret A, Orti R, Alonso D. Molecular bases of the treatment of Alzheimer\u2019s disease with antioxidants: prevention of oxidative stress. Mol Aspects Med. 2004;25(1\u20132):117\u201323.","journal-title":"Mol Aspects Med"},{"issue":"7","key":"803_CR403","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11745-017-4260-3","volume":"52","author":"S Yamashita","year":"2017","unstructured":"Yamashita S, Hashimoto M, Haque AM, Nakagawa K, Kinoshita M, Shido O, et al. Oral Administration of Ethanolamine Glycerophospholipid Containing a high level of Plasmalogen improves memory impairment in amyloid beta-infused rats. Lipids. 2017;52(7):575\u201385.","journal-title":"Lipids"},{"key":"803_CR404","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ebiom.2017.02.012","volume":"17","author":"T Fujino","year":"2017","unstructured":"Fujino T, Yamada T, Asada T, Tsuboi Y, Wakana C, Mawatari S, et al. Efficacy and blood plasmalogen changes by Oral Administration of Plasmalogen in patients with mild Alzheimer\u2019s disease and mild cognitive impairment: a Multicenter, Randomized, Double-blind, placebo-controlled trial. EBioMedicine. 2017;17:199\u2013205.","journal-title":"EBioMedicine"},{"issue":"10","key":"803_CR405","doi-asserted-by":"publisher","first-page":"e24777","DOI":"10.1371\/journal.pone.0024777","volume":"6","author":"G Astarita","year":"2011","unstructured":"Astarita G, Jung KM, Vasilevko V, Dipatrizio NV, Martin SK, Cribbs DH, et al. Elevated stearoyl-CoA desaturase in brains of patients with Alzheimer\u2019s disease. PLoS ONE. 2011;6(10):e24777.","journal-title":"PLoS ONE"},{"issue":"3","key":"803_CR406","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3233\/JAD-2012-110629","volume":"29","author":"SC Cunnane","year":"2012","unstructured":"Cunnane SC, Schneider JA, Tangney C, Tremblay-Mercier J, Fortier M, Bennett DA, et al. Plasma and brain fatty acid profiles in mild cognitive impairment and Alzheimer\u2019s disease. J Alzheimers Dis. 2012;29(3):691\u20137.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"803_CR407","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1038\/s41467-022-29506-y","volume":"13","author":"LK Hamilton","year":"2022","unstructured":"Hamilton LK, Moquin-Beaudry G, Mangahas CL, Pratesi F, Aubin M, Aumont A, et al. Stearoyl-CoA desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u2019s disease mouse model. Nat Commun. 2022;13(1):2061.","journal-title":"Nat Commun"},{"issue":"4","key":"803_CR408","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.stem.2015.08.001","volume":"17","author":"LK Hamilton","year":"2015","unstructured":"Hamilton LK, Dufresne M, Joppe SE, Petryszyn S, Aumont A, Calon F, et al. Aberrant lipid metabolism in the Forebrain Niche suppresses adult neural stem cell proliferation in an animal model of Alzheimer\u2019s Disease. Cell Stem Cell. 2015;17(4):397\u2013411.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"803_CR409","doi-asserted-by":"publisher","first-page":"7742","DOI":"10.1038\/s41598-024-58272-8","volume":"14","author":"LK Hamilton","year":"2024","unstructured":"Hamilton LK, M\u2019Bra PEH, Mailloux S, Galoppin M, Aumont A, Fernandes KJL. Central inhibition of stearoyl-CoA desaturase has minimal effects on the peripheral metabolic symptoms of the 3xTg Alzheimer\u2019s disease mouse model. Sci Rep. 2024;14(1):7742.","journal-title":"Sci Rep"},{"issue":"3","key":"803_CR410","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/j.1365-2125.2012.04374.x","volume":"75","author":"PC Calder","year":"2013","unstructured":"Calder PC. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br J Clin Pharmacol. 2013;75(3):645\u201362.","journal-title":"Br J Clin Pharmacol"},{"issue":"6 Suppl","key":"803_CR411","doi-asserted-by":"publisher","first-page":"S1505","DOI":"10.1093\/ajcn\/83.6.1505S","volume":"83","author":"PC Calder","year":"2006","unstructured":"Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr. 2006;83(6 Suppl):S1505\u201319.","journal-title":"Am J Clin Nutr"},{"issue":"5499","key":"803_CR412","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1126\/science.290.5499.2140","volume":"290","author":"AM de Urquiza","year":"2000","unstructured":"de Urquiza AM, Liu S, Sjoberg M, Zetterstrom RH, Griffiths W, Sjovall J, et al. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science. 2000;290(5499):2140\u20134.","journal-title":"Science"},{"issue":"6","key":"803_CR413","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1139\/bcb-2015-0149","volume":"94","author":"MO Grimm","year":"2016","unstructured":"Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Blumel T, Stotzel H, et al. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-beta by affecting insulin-degrading enzyme. Biochem Cell Biol. 2016;94(6):534\u201342.","journal-title":"Biochem Cell Biol"},{"issue":"10","key":"803_CR414","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1001\/archneur.63.10.1402","volume":"63","author":"Y Freund-Levi","year":"2006","unstructured":"Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, et al. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch Neurol. 2006;63(10):1402\u20138.","journal-title":"Arch Neurol"},{"issue":"17","key":"803_CR415","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1001\/jama.2010.1510","volume":"304","author":"JF Quinn","year":"2010","unstructured":"Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, et al. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010;304(17):1903\u201311.","journal-title":"JAMA"},{"issue":"2","key":"803_CR416","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/gerona\/glv109","volume":"71","author":"SC Strike","year":"2016","unstructured":"Strike SC, Carlisle A, Gibson EL, Dyall SC. A high Omega-3 fatty acid multinutrient supplement benefits cognition and mobility in older women: a Randomized, Double-blind, placebo-controlled pilot study. J Gerontol Biol Sci Med Sci. 2016;71(2):236\u201342.","journal-title":"J Gerontol Biol Sci Med Sci"},{"issue":"1","key":"803_CR417","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3233\/JAD-130722","volume":"38","author":"L Shinto","year":"2014","unstructured":"Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, et al. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer\u2019s disease. J Alzheimers Dis. 2014;38(1):111\u201320.","journal-title":"J Alzheimers Dis"},{"issue":"3","key":"803_CR418","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s00213-012-2848-0","volume":"225","author":"LK Lee","year":"2013","unstructured":"Lee LK, Shahar S, Chin AV, Yusoff NA. Docosahexaenoic acid-concentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology. 2013;225(3):605\u201312.","journal-title":"Psychopharmacology"}],"container-title":["Molecular Neurodegeneration"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00803-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13024-025-00803-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13024-025-00803-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T20:11:30Z","timestamp":1738008690000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularneurodegeneration.biomedcentral.com\/articles\/10.1186\/s13024-025-00803-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":418,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["803"],"URL":"https:\/\/doi.org\/10.1186\/s13024-025-00803-6","relation":{},"ISSN":["1750-1326"],"issn-type":[{"value":"1750-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have reached consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"11"}}